The present invention relates to an apparatus and methods for delivering laser energy having a short pulse duration (e.g., less than about 1 nanosecond) and high energy output per pulse (e.g., greater than about 200 millijoules).
Disclosed herein are subnanosecond pulse duration laser systems, which are useful for a variety of cosmetic and medical treatments. A subnanosecond pulse duration laser apparatus includes: (a) a resonator having a first mirror at one end of said resonator and a second mirror at the opposite end of said resonator, wherein both said first mirror and said second mirror are substantially totally reflective; and (b) a lasing medium, an ultrafast switching element and a polarizing element along the optical axis of said resonator, wherein a first drive circuit is connected to a first end of the ultrafast switching element and a second drive circuit is connected to a second end of the ultrafast switching element, wherein said apparatus generates a modelocked pulse by the first circuit applying a periodic voltage waveform to the first end of the ultrafast switching element and then amplifies the modelocked pulse by the first circuit applying a first constant voltage to the first end of the ultrafast switching element and maintaining an effective reflectivity of the second mirror at substantially 100%, and then extracts the amplified modelocked pulse by the second circuit applying a second constant voltage to the second end of the ultrafast switching element and maintaining an effective reflectivity of the second mirror at substantially 0%.
Subnanosecond pulse duration laser systems that are useful for cosmetic and medical applications provide pulsed laser energy that delivers at least about 100 mJ/pulse and up to about 800 mJ/pulse. An exemplary output energy has about 200 mJ/pulse. Likewise, such subnanosecond laser systems have pulse durations of about 100 picoseconds to less than 1000 ps, and preferably pulse durations of about 200 ps to 600 ps, or about 400-500 ps.
Subnanosecond laser systems are particularly useful in the treatment of skin and skin lesions. For example, tattoo removal requires delivery of subnanosecond laser pulses to the dermis, where photomechanical damage to ink particles facilitates the removal of the tattoo by the subject's immune system. Colored tattoos or heavily shaded tattoos are easily treated by such subnanosecond systems, using fewer treatments to achieve a desired reduction in the visible appearance of the tattoo. Other skin treatments include benign pigmented lesions, where applying subnanosecond pulsed laser energy to benign pigmented lesions decreases the visible appearance of the pigmented lesions. Similar effects are seen in the treatment of vascular lesions, where applying subnanosecond pulsed laser energy to the vascular lesion thereby decreases the visible appearance of the vascular lesions.
In addition to pigmented lesions, scars, wrinkles and striae are also treatable using subnanosecond pulsed laser energy. The laser energy can be used to debulk the scars, and it creates generally areas in the tissue of microdamage from photomechanical effects. This has tissue-inductive effects, resulting in the evening-out of tissue surfaces and the improvement in coloration and texture of the target tissue. In certain aspects of the invention, the subnanosecond pulsed laser energy is modified with a lens, thereby producing a treatment beam having a nonuniform energy cross section characterized by of a plurality of regions of relatively high energy per unit area dispersed within a background region of relatively low energy per unit area. Such systems outputting subnanosecond pulse laser energy in a non-uniform beam deliver sufficient energy to target tissue illuminated by regions of relatively high energy per unit area to heat the so-illuminated portions of the target tissue to a first temperature T1 and wherein the substantially uniform background region of relatively low energy per unit area delivers sufficient energy to target tissue illuminated by the regions of relatively high energy per unit area to heat the so illuminated portions of the target tissue to a second temperature T2, wherein T2 is less than T1.
In other embodiments, the invention provides for wavelength shifted subnanosecond pulse laser, that can be frequency matched to the absorption spectrum of a skin pigment or tattoo ink. A method for shifting the wavelength of a subnanosecond pulse laser apparatus includes maintaining a relatively constant pulse duration by using the pulse as a pump for a laser resonator with a short roundtrip time by including a laser crystal with high absorption coefficient at the wavelength of the short pulse; where the round trip time of the short laser resonator is substantially shorter than the pumping laser pulse duration.
The invention will be more completely understood through the following detailed description, which should be read in conjunction with the attached drawings. Detailed embodiments of the invention are disclosed herein, however, it is to be understood that the disclosed embodiments are merely exemplary of the invention, which may be embodied in various forms. Therefore, specific functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the invention in virtually any appropriately detailed embodiment.
Lasers are recognized as controllable sources of radiation that is relatively monochromatic and coherent (i.e., has little divergence). Laser energy is applied in an ever-increasing number of areas in diverse fields such as telecommunications, data storage and retrieval, entertainment, research, and many others. In the area of medicine, lasers have proven useful in surgical and cosmetic procedures where a precise beam of high energy radiation causes localized heating and ultimately the destruction of unwanted tissues. Such tissues include, for example, subretinal scar tissue that forms in age-related macular degeneration (AMD) or the constituents of ectatic blood vessels that constitute vascular lesions.
Most of today's aesthetic lasers rely on heat to target tissue and desired results must be balanced against the effects of sustained, elevated temperatures. The principle of selective photothermolysis underlies many conventional medical laser therapies to treat diverse dermatological problems such as leg veins, portwine stain birthmarks, and other ectatic vascular and pigmented lesions. The dermal and epidermal layers containing the targeted structures are exposed to laser energy having a wavelength that is preferentially or selectively absorbed in these structures. This leads to localized heating to a temperature (e.g., to about 70 degrees C.) that denatures constituent proteins or disperses pigment particles. The fluence, or energy per unit area, used to accomplish this denaturation or dispersion is generally based on the amount required to achieve the desired targeted tissue temperature, before a significant portion of the absorbed laser energy is lost to diffusion. The fluence must, however, be limited to avoid denaturing tissues surrounding the targeted area.
Fluence, however, is not the only consideration governing the suitability of laser energy for particular applications. The pulse duration and pulse intensity, for example, can impact the degree to which laser energy diffuses into surrounding tissues during the pulse and/or causes undesired, localized vaporization. In terms of the pulse duration of the laser energy used, conventional approaches have focused on maintaining this value below the thermal relaxation time of the targeted structures, in order to achieve optimum heating. For the small vessels contained in portwine stain birthmarks, for example, thermal relaxation times and hence the corresponding pulse durations of the treating radiation are often on the order of hundreds of microseconds to several milliseconds.
Cynosure's PicoSure™ brand laser system is the first aesthetic laser to utilize picosecond technology which delivers laser energy at speeds measured in trillionth of seconds (10−12). PicoSure systems deliver both heat and mechanical stress to shatter the target from within before any substantial thermal energy can disperse to surrounding tissue. Clinical results show a higher percentage of clearance achieved in fewer treatments. PicoSure systems, employing Pressure Wave™ technology, is useful for multiple aesthetic indications such as pigmented lesions and multi-colored tattoo removal as well as dermal rejuvenation.
An exemplary PicoSure™ brand picosecond laser apparatus is detailed in our U.S. Pat. Nos. 7,586,957 and 7,929,579, incorporated herein by reference. Such a laser apparatus provides for extremely short pulse durations, resulting in a different approach to treating dermal conditions than traditional photothermal treatments. Laser pulses having durations below the acoustic transit time of a sound wave through targeted particles are capable of generating photomechanical effects through pressure built up in the target particles. Photomechanical processes can provide commercially significant opportunities, particularly in the area of treating skin pigmentations. Coupled with high energy output, such lasers described above are particularly suitable for the following exemplary applications. Table 1 provides fluence values for particular spot sizes, for a subnanosecond pulse laser outputting about 200 mJ/pulse.
A. Tattoo Removal
The incidence of tattoos in the U.S. and other populations, for example, continues at a significant pace. Because tattoo pigment particles of about 1 micron in diameter or less may be cleared from the body via ordinary immune system processes, stable tattoos are likely composed of pigment particles having diameters on the order of 1-10 microns or more. The acoustic transit time of a sound wave in a particle of tattoo pigment is calculated by dividing the radius of the particle by the speed of sound in the particle. As the speed of sound in tattoo pigment, as well as many solid media is approximately 3000 meters/second, the acoustic transit time across such particles, and consequently the laser pulse duration required to achieve their photomechanical destruction of the tattoo pigment is as low as hundreds of picoseconds.
In addition to such short pulse durations, high energy laser pulses are needed for significant disruption of tattoo pigment particles. Given that most tattoos are on the order of multiple centermeters in size, the ideal laser for tattoo removal should ideally employ a beam having a relatively large spot size. Fluences of several joules per square centimeter and treatment spot sizes of a few millimeters in diameter translate to a desired laser output with several hundred millijoules (mJ) per pulse or more, and are suitable for tattoo removal.
An exemplary sub-nanosecond tattoo removal laser apparatus as described in our U.S. Pat. Nos. 7,586,957 and 7,929,579 and as described herein is used to generate pulsed laser energy having a subnanosecond pulse duration of about 100-950 picoseconds, preferably with an energy delivery of about 200-750 mJ/pulse. Such exemplary subnanosecond laser apparatus includes a resonator with two substantially totally reflective mirrors at opposite ends of its optical axis. An alexandrite crystal lasing medium, a polarizer, and a Pockets cell are positioned along this optical axis. An optical flashlamp is also included for pumping the alexandrite lasing medium, which generates laser energy having a wavelength in the range of about 700-950 nm.
The pulsed laser energy described above is generated by pumping the lasing medium and first establishing a modelocked pulse oscillating in the resonator. In the modelocked pulse operating mode, a time-dependent voltage waveform, as described herein, is applied to the Pockets cell. This waveform results from the sum of a constant baseline voltage and a time-dependent differential voltage. The baseline voltage is in the range of 1000-1500 volts (representing 40%-60% of the Pockets cell quarter wave voltage, or 2500 volts) and is negatively offset or modulated by the time-dependent differential voltage, having an amplitude in the range of 250-750 volts (representing 10%-30% of the Pockets cell quarter wave voltage). The period of the resulting voltage waveform is in the range from 5-10 ns and is equal to the round trip time of the oscillating laser energy in the resonator. The voltage applied to the Pockels cell is thus modulated at a frequency in the range from 100-200 MHz.
Subsequently, the modelocked pulse established as described above is amplified by discharging the Pockels cell to essentially 0 volts. Oscillating laser energy is reflected between the mirrors at each end of the resonator, with essentially no losses. This laser energy therefore rapidly increases in amplitude by extracting energy previously pumped and stored in the alexandrite crystal during modelocking. When the laser energy has reached the desired energy level as indicated above, it is extracted from the resonator by applying the quarter wave voltage of 2500 volts to the Pockels cell.
The switching electronics used to operate the laser in modelocked pulse and amplification modes, and finally to extract the amplified pulse as discussed above, comprise five MOFSET switches, two high speed diodes, and three voltage sources having voltages V1 in the range of +1000 to +1500 volts, V2 in the range of +250 to +750 volts, and V3 in the range of −1000 to −1500 volts. The switches, diodes, and voltage sources are configured as shown above.
Laser energy having the pulse duration and energy as described is applied to a patient undergoing treatment for the removal of a tattoo. This laser energy is applied over the course of a 30-minute treatment session to all areas of the skin having undesired tattoo pigment particles. Photomechanical disruption of these particles is effected using the short pulse duration (below the transit time of a sound wave through the targeted tattoo pigment particles), together with a fluence in the range of 2-4 J/cm2. This fluence is achieved in the above device with a laser energy spot diameter of about 5 mm.
Most if not all of the undesired tattoo pigment particles Are effectively photomechanically disrupted, destabilized, and/or broken apart using one or two treatments. As a result, the disrupted particles are cleared from the body via normal physiological processes, such as the immune response. The tattoo is thus eventually cleared from the skin with no remaining visible signs. Such subnanosecond laser devices are particularly well suited for removal of tattoos having colored inks, colors being far more recalcitrant to treatment with traditional laser treatments than black inks. Likewise, tattoos having heavy coloration or shading are more amenable to treatment using subnanosecond laser systems. Similarly, subnanosecond lasers provide for tattoo removal with fewer treatments than compared to traditional laser systems.
B. Benign Pigmented Lesions
Numerous types of benign pigmented lesions of the skin, connective tissue, mucosal tissue and vasculature are treatable using the subnanosecond laser systems described herein.
Nevi are a broad category of generally well circumscribed and chronic lesions of the skin that can be congenital or develop later in life. Vascular nevi such as hemangioma, are derived from structures of the blood vessels. Epidermal nevi such as seborrheic keratoses are derived from keratinocytes. Connective tissue nevi are derived from connective tissues. Melanocytic nevi such as nevomelanocytic nevi are pigmented lesions that morphologically can be flat macules or raised papules, and are characterized by clusters of melanocytes. In addition to the above, dermal melanocytoma (blue nevi), acral nevi, nevus spilus (also known as speckled lentiginous nevus), nevus of Ota/Ito and Becker's nevus are all exemplary and non-limiting nevi that are suitable for treatment using the above laser apparatus.
Lentigines are similarly treatable. These are pigmented spots on the skin typically small and with a clearly-defined edge, surrounded by normal-appearing skin. These are benign melanocytic hyperplasias that are linear rather than raised, with the melanocytes generally restricted to the cell layer directly above the basement membrane of the epidermis. Lentigines also appear in mucosal tissues. Lentigines are distinguished from ephelids (freckles) based on melanocyte proliferation, where lentigines display an increased number of melanocytes but ephelids have normal numbers of melanocytes that overexpress melanin.
Other forms of congenital dermal pigmentation are equally suitable to treatment using the above laser apparatus, usually being larger areas requiring larger laser spot sizes. For example, café au lait macules, congenital dermal melanocytosis, and dermal melanocytosis are all exemplary types of benign, flat, pigmented birthmarks, generally with wavy borders and irregular shapes. Other exemplary pigmented lesions develop as one ages, or due to hormonal changes, infection or treatment with pharmaceutical agents. For example, melasma a/k/a chloasma faciei (colloquially “the mask of pregnancy”) is a tan or dark skin discoloration. Postinflammatory hyperpigmentation (also known as postinflammatory hypermelanosis) can result from natural or iatrogenic inflammatory conditions, and are commonly caused by increased epidermal pigmentation. This can occur through increased melanocyte activity or by dermal melanosis from melanocyte damage with melanin migration from the epidermis into the dermis. Drug-induced pigmentation of the skin may occur as a consequence of drug administration, related to deposition of the drug in the tissues. Minocycline is known for this effect. Pigmented lesions aren't confined to the dermal tissues. Ochronosis is a pigmented lesion caused by the accumulation of homogentisic acid in connective tissues. In addition, melanonychia is aberrant pigmentation of the normal nail plate. These exemplary conditions are all suitable to treatments using the above described laser systems.
To treat the above conditions, it is generally accepted that destruction of melanosomes is pulse-width-dependent. Using traditional laser systems, pulse durations of between 40 nanoseconds and 750 nanoseconds have been shown to be effective, but longer pulse durations (eg, 400 microseconds) do not appreciably damage the melanosomes, Likewise, Q-switched Nd:YAG laser systems have shown immediate skin whitening with threshold energy exposures generating fluence values of 0.11, 0.2, and 1 mJ/cm2 respectively at 355, 532, and 1064 nm wavelengths.
Melanin has a broad absorption spectrum, and lasers emitting at wavelengths of about 500-1100 nm provide for good skin penetration and selective melanosome absorption without undue hemoglobin absorption. Exemplary lasers include 510-nm pulsed dye, 532-nm frequency-doubled Nd:YAG, 694-nm ruby, 755-mn alexaridrite, and near-infrared Nd:YAG lasers emitting at 1064 nm. Other lasers have been used successfully to treat pigmented lesions, including argon, krypton, copper, carbon dioxide, and Er:YAG lasers, but with these systems there is a trade-off between pigment destruction and collateral damage to other chromophores and tissues.
An exemplary subnanosecond laser system for treating pigmented lesions is described by the above apparatus generating pulsed laser energy having a pulse duration of about 100-950 picoseconds with an energy output of about 200-750 mJ/pulse. Laser energy having a wavelength in the range of 700-950 nm provides excellent specificity for melanin. Photomechanical disruption is effected using the short pulse duration (below the transit time of a sound wave through the targeted pigment particles), together with a fluence in the range of 2-4 J/cm2. This fluence is achieved with a laser energy spot diameter of about 5 mm, which can be changed according to the area of the target. Treatment times will vary with the degree of pigmentation and the shapes of the targets. In addition to decreasing the visible appearance of pigmented lesions, photomechanical microdamage to target tissues caused by subnanosecond pulses promotes a healing response that can decrease the size and shape of the lesion.
C. Vascular Lesions
Vascular lesions refer to a broad category of pigmented malformations, generally congenital, that are due to localized defects of vascular morphogenesis. These include capillary, venous, arteriovenous, and lymphatic malformations as well as lesions involving only the skin and subcutaneous tissues. Exemplary non-limiting examples include capillary vascular malformation, telangiectasis, cherry angioma, angiofibroma, dyschromia, port wine stain birthmarks, strawberry hemangiomas, rosacea, pyogenic granuloma and other vascular malformations.
The targeted chromophore for vascular lesions is intravascular oxyhemoglobin, with maximal light absorption occurring in the range of yellow and green light, i.e., at 418, 542, and 577 nm and in the near-infrared spectrum. Traditional approaches to treating vascular lesions involved pulsed dye lasers, typically operating at wavelengths such as 585-nm or 595-nm, frequency-doubled Nd:YAG lasers at wavelengths of 532 nm, and infrared lasers such as alexandrite or diode lasers having wavelengths of 1064 nm. Histologically, the targets of treatment are postcapillary venules, capillaries, or arterioles, generally at depths range from 200 to 300 μm. Accordingly, a deeper penetration of the laser beam is desirable, particularly where heating of the surface skin can lead to excessive scarring. Typical treatment parameters involve fluences of 8 to 10 J/cm2, and a 5-10 mm spot size.
An exemplary system to treat vascular lesions is described by an apparatus generating pulsed laser energy having a pulse duration of about 100-950 ps with energies of about 200-750 mJ/pulse. Laser energy having a wavelength in the range of 500-600 nm provides excellent specificity for oxyhemoglobin. Photomechanical disruption is effected using the short pulse duration (below the transit time of a sound wave through the targeted pigment particles), together with a fluence in the range of 7-10 j/cm2. This fluence is achieved with a laser energy spot diameter of about 5 mm, which can be changed according to the area of the target. Treatment times will vary with the degree of pigmentation and the shapes of the targets.
D. Scar Tissue
Various types of scarring are treatable using lasers. Exemplary non-limiting types include hypertrophic scars, keloids and atrophic scars. Hypertrophic scars are cutaneous deposits of excessive amounts of collagen. These give rise to a raised scar, and are commonly seen at prior injury sites particularly where the trauma involves deep layers of the derrnis, i.e., cuts and bums, body piercings, or from pimples. Hypertrophic scars commonly contain nerve endings are vascularized, and usually do not extend far beyond the boundary of the original injury site.
Similarly, a keloid is a type of scar resulting from injury, that is composed mainly of either type III or type I collagen. Keloids result from an overgrowth of collagen at the site of an injury (type III), which is eventually replaced with type 1 collagen, resulting in raised, puffy appearing firm, rubbery lesions or shiny, fibrous nodules, which can affect movement of the skin. Coloration can vary from pink to darker brown.
Atrophic scarring generally refers to depressions in the tissue, such as those seen resulting from Acne vulgaris infection. These “ice pick” scars can also be caused by atrophia maculosa varioliformis cutis (AMVC), which is a rare condition involving spontaneous depressed scarring, on the cheeps, temple area and forehead.
Laser treatments are suitable for hypertrophic and atrophic scars, and keloids, and common approaches have employed pulsed dye lasers in such treatments. In raised scars, this type of therapy appears to decrease scar tissue volume through suppression of fibroblast proliferation and collagen expression, as well as induction of apoptotic mechanisms. Combination treatment with corticosteroids and cytotoxic agents such as fluorouracil can also improve outcome. In atrophic scars, treatments can even out tissue depths.
Striae (stretch marks) are a form of scarring caused by tearing of the dermis. They result from excess levels of glucocorticoid hormones, which prevent dermal fibroblasts from expressing collagen and elastin. This leads to dermal and epidermal tearing. Generally, 585-nm pulsed dye laser treatments show subjective improvement, but can increase pigmentation in darker skinned individuals with repeated treatments. Fractional laser resurfacing using scattered pulses of light has been attempted. This targets small regions of the scar at one time, requiring several treatments. The mechanism is believed to be the creation of microscopic trauma to the scar, which results in new collagen formation and epithelial regeneration. Similar results can be achieved, albeit to the total scar, through the use of modified laser beams as described in our U.S. Pat. No. 7,856,985, detailing the use of non-uniform beam radiation to create within the beam area, discrete microtrauma sites against a background of tissue inducing laser radiation.
An exemplary system for treating scars is described by the above apparatus generating pulsed laser energy having a pulse duration of about 100-950 ps with energies of about 200-750 mJ/pulse. Laser energy having a wavelength in the range of 500-1100 nm provides excellent specificity for collagen. Photomechanical disruption of the scar tissue is effected using the short pulse duration (below the transit time of a sound wave through the targeted tissue), together with a fluence in the range of 2-4 J/cm2. This fluence is achieved with a laser energy spot diameter of about 5 mm, which can be changed according to the area of the target. Treatment times wilt vary with the degree of scarring and the shapes of the targets. The photomicrodamage from subnanosecond pulses can debulk the scar, resolve coloration differences between it and healthy tissues, and promotes tissue healing responses which have the effect of softening the scar. Modifying the output beam as described in U.S. Pat. No. 7,856,985 provides a particularly useful approach to reducing scar appearance and inducing epithelial restoration within the scar.
E. Dermal Rejuvenation
A non-uniform output beam is delivered to tissue from a source of light as described in our patent applications U.S. Ser. Nos. 11/347,672; 12/635,295; 12/947,310, and PCT/US10/026432. The non-uniform beam is characterized by a cross-section corresponding to an array of relatively small, relatively high-intensity, spaced-apart central regions superimposed on a relatively large, and relatively low-intensity background region. Operatively, this produces within the area of the beam, relatively hotter regions and relatively cooler regions. This non-uniform beam provides for unique physiological effects as compared to standard uniform output laser beams that demonstrate relative uniform energy output across the planar surface of the beam. Such effects are related to the fluence and duration of the light pulse, and include various quantifiable physiological effects. Exemplary temperature dependent effects include but are not limited to parakeratosis, perivascular mononuclear infiltration, keratinocyte necrosis, collagen denaturation, and procollagen expression in dermal cells. Other cellular markers (e.g., nucleic acids and proteins) are useful in detecting more subtle responses of skin to less aggressive treatments.
Various combinations of wavelength, power, spot size, treatment duration and recovery intervals are possible, and the particular combination is selected based on the desired therapeutic effect. For example, in treating age spots and pigmentation a device wavelength is chosen to be preferentially absorbed by melanin (between 400 nm and 1400 nm, and more preferably 500 nm to 1100 nm). Accordingly, an exemplary device for such purposes has a wavelength of about 750 nm, a pulse duration of about 500 to 900 ps and an overall treatment area of 1 cm2 that is output as a non-uniform beam characterized by a cross-section corresponding to an array of relatively small, relatively high intensity, spaced-apart central regions superimposed on a relatively large, relatively low intensity background region. If such exemplary device has about 0.2 J of energy delivered into the treatment area, or about 0.2 J/cm2 average fluence. Using a lens that renders the output beam non-uniform, delivering relatively high intensity spaced-apart central regions at 1 mm center-to-center distances surrounded by low intensity background regions, in such device, there are about 115 discrete subzones (e.g., combined areas of relatively high and relatively low intensity) per square centimeter in that arrangement, which results in about 1.73 mJ delivered to each subzone. Within each subzone, if the high intensity spaced-apart central region is about 120 μm in diameter and approximately 80% of the energy is delivered into the high intensity spaced-apart central regions, then the fluence within each high intensity region is approximately 12.2 J/cm2. That fluence value in the device is comparable to the treatment fluence delivered by high-powered Alexandrite uniform spot lasers having pulse durations of about 50 ns, which are the systems commonly used to treat uneven skin pigmentation in clinical settings by medically trained professionals. Unlike uniform-beam devices, using the non-uniform beam technology for any individual treatment session, only a relatively small percentage of the irradiated skin surface is actually treated with high intensity light, and thereby only a subpopulation of melanocytes receive a cellular disruptive dose of thermal energy, leading to a relatively smaller percentage of melanocyte damage per treatment area compared to uniform beam treatments. This advantageously reduces any sharp boundaries between treated and untreated skin, thereby reducing the need for special operator skills and techniques.
Good cosmetic effects can be produced by such non-uniform irradiation of tissues, due to differential effects occurring in both the relatively high intensity spaced-apart central regions of the beam and in the relatively low intensity background region. By way of illustration, within the spaced-apart central regions it is possible to cause relatively localized heating of tissues therein to a temperature T1 sufficient to heat up the melanocytes to a temperature sufficient to disrupt cellular processes (e.g., about 45 degrees C. or higher), impair their function and decrease their pigment output. Simultaneously during the treatment, within the low intensity background regions at a lower relative temperature T2 (e.g., less than 45 degrees C. to about 35 degrees C.), cellular growth and collagen production is induced without causing undesirable thermal effects to the treated tissue within the lower energy regions. The result of such treatment is an improvement to both skin texture and coloration. Other differential effects on tissues can be realized as well. By way of further example, temperatures at about 70 degrees C. can serve to denature collagen, so within the spaced-apart central regions it is possible to cause relatively localized heating of tissues therein to a temperature T1 sufficient to remodel collagen structures, while simultaneously within the low intensity background regions at a lower relative temperature T2, collagen production is induced without causing undesirable thermal effects to the treated tissue within the background regions.
Likewise, by decreasing the amount of energy delivered by the beam it is possible to select for specific thermal effects on tissues. For example, in our U.S. Pat. No. 7,856,985 we disclose collagen remodeling at temperatures where T1 is approximately 70 degrees C. or greater while the irradiated tissues in the cooler regions of the beam (e.g., at temperature T2) are not substantially adversely affected. The device used generating a non-uniform beam output, permits more selective application with less collateral tissue damage. However, for reducing age spots and evening skin pigmentation, melanocyte cell membrane damage with consequent cellular disruption is achieved at lower T1 temperatures of approximately 45-50 degrees C. (unless such heating is quite transient). Higher temperatures are suitable, and cause permanent disruption of melanocytes, but above 50 degrees C. more extensive thermal effects are seen in the tissue, that must be evaluated against therapeutic benefits. Below the temperature threshold for causing cellular damage and disruption, positive effects on skin tone are seen. At a T1 temperature of less than about 50 degrees C., cells are not substantially damaged but are still induced to generate a healing response and express elastin, procollagen, keratin and other markers for dermal rejuvenation. So a device generating regions capable of elevating tissue temperatures to a T1 of about 45 degrees C. against a background T2 of about 37 degrees.
The overall effect of treatments on skin tone, wrinkling and pigmentation provide the best indication of therapeutic efficacy, but such treatments also leave histological evidence that can be discerned. At higher energies, thermal damage is easy to detect. For more moderate energies, microthermal damage can produce effects that are seen with magnification although erythema provides a good marker for microthermal injury and it does not require microscopic examination of tissues from the treatment site. Generally, in the absence of any visually observable erythema, the cellular effects will be more subtle, or may take longer to manifest themselves or may require multiple treatments before visual improvement of the skin is seen. At lower output energies, shorter pulse durations, and longer intervals between treatments, it is advantageous to use more sensitive techniques to assay for cellular changes. Certain techniques provide for quantitative analysis, which are correlated to describe a dose-response relationship for the non-uniform beam, as it is used in dermal rejuvenation applications. Such techniques include but are not limited to RT-PCR and/or real-time PCR, either of which permits quantitative measurements of gene transcription, useful to determine how expression of a particular marker gene in the treated tissues changes over time. In addition to nucleic acid-based techniques, quantitative proteomics can determine the relative protein abundance between samples. Such techniques include 2-D electrophoresis, and mass spectroscopy (MS) such as MALDI-MS/MS and ESI-MS/MS. Current MS methods include but are not limited to: isotope-coded affinity tags (ICAT); isobaric labeling; tandem mass tags (TMT); isobaric tags for relative and absolute quantitation (iTRAQ); and metal-coded tags (MeCATs). MeCAT can be used in combination with element mass spectrometry ICP-MS allowing first-time absolute quantification of the metal bound by MeCAT reagent to a protein or biomolecule, enabling detection of the absolute amount of protein down to attomolar range.
An exemplary system for dermal rejuvenation is described by the above apparatus generating pulsed laser energy having a pulse duration of about 100-950 ps with energies about 200-750 mJ/pulse. Laser energy having a wavelength in the range of 500-1100 nm provides excellent specificity for collagen. Photomechanical disruption of the target tissue is effected using the short pulse duration (below the transit time of a sound wave through the targeted tissue), together with a fluence in the range of 2-4 J/cm2. This fluence is achieved with a laser energy spot diameter of about 5 mm, which can be changed according to the area of the target. Treatment times will vary according to the desired effects. Modifying the output beam as described in U.S. Pat. No. 7,856,985 provides a particularly useful approach to rejuvenating tissue and inducing collagen and epithelial cell restoration within the tissue.
F. Frequency Shifting
The subnanosecond laser systems may include a frequency shifting apparatus, which can be matched to the absorbtion spectrum of endogenous skin pigmentation or exogenous tattoo pigments to be targeted. Such a system comprises a rare earth doped laser gain crystal for example Nd:YVO4, and a frequency doubling crystal for example KTP. Rare earth doped laser crystals that generate a polarized laser beam like Nd:YVO4 are preferred. Crystals like Nd:YAG or Nd doped glasses can be used with an additional polarizing element in the resonator. The input side of the Nd:YVO4 crystal is AR coated for the alexandrite wavelength and HR coated for 1064 nm. The output side of the crystal is HR coated for the alexandrite wavelength and has approximately 20 to 70% reflectivity at 1064 nm. The Nd:YVO4 crystal length is chosen so that it absorbs most (greater than 90%) of the alexandrite laser pulse in the two passes through the crystal. For Nd doping in the range 1 to 3% the Nd:YVO4 crystal can be chosen to be around 3 mm long. There are no other optical elements in the resonator and the resonator length is equal to the crystal length 3 mm. That means the resonator round-trip time is around 36 ps—this is substantially less than the pulse duration of the alexandrite pumping pulse (around 500 to 800 ps). The 1064 nm pulse generated in the very short round trip time Nd:YVO4 resonator will be slightly longer than the pumping alexandrite pulse and it will be shorter than 1000 ps. The quantum defect will account for a 30% pulse energy loss and another 15% of the energy is likely to be lost due to coatings, crystal and geometry imperfection for an overall energy conversion efficiency of around 50 to 60%. That means a 100 mJ pulse energy can be expected at 1064 nm. Conservatively it is estimated that the second harmonic conversion in the KTP crystal will be around 50% and a 50 mJ pulse energy can be expected at 532 nm. The red tattoo pigments have high absorption at 532 nm. A 50 mJ 532 nm pulse with a pulse duration less than 1000 ps is expected to be effective at disrupting red tattoo granules.
When the Nd:YAG crystal or Nd doped glasses are used in the short resonator an extra polarizing element has to be used to generate a polarized 1064 nm pulse. The cross-section depicts a short Nd:YAG resonator consisting of two identically shaped crystals with one face cut at an angle that is AR coated for the alexandrite wavelength and polarized coating for 1064 nm (high p transmission). The flat faces of the two Nd:YAG crystals have different coatings—one is AR coated at 755 nm and FIR coated at 1064 nm and the other is HR coated for 755 nm and has an output coupler reflectivity around 50 to 80% for 1064 nm. The higher output coupler reflectivity for the Nd:YAG crystal compared to the Nd:YVO4 crystal is due to the lower gain cross-section in Nd:YAG.
Generating a short 1064 nm pulse depends on two factors. One is the pulse duration of the pumping alexandrite pulse. Shorter pumping pulses will lead to shorter generated pulses at 1064 nm. The second factor is the 1064 nm resonator round trip time that is determined by the length of the Nd doped crystal. Shorter crystals lead to shorter roundtrip time, however the crystal has to be sufficiently long to absorb greater than 90% of the alexandrite energy. For example, an 8 mm long Nd:YAG resonator would have a 97 ps round trip time. That round trip time is longer than the round trip time that can be achieved with a Nd:YVO4 resonator, but still it is much shorter than the pumping Alexandrite laser pulse duration. One possible way to shorten the crystal length is to tune the alexandrite laser in the range 750 to 760 nm for maximum absorption in the Nd doped crystal and use the minimum possible crystal length. In addition, tuning the atexandrite laser in the range 750 to 757 nm allows for the alexandrite wavelength to be set to avoid the excited state absorption bands in the Nd ion as described by Kliewer and Powell, IEEE Journal of Quantum Electronics vol. 25, page 1850-1854, 1989.
This application is a continuation of U.S. patent application Ser. No. 15/721,714, filed Sep. 29, 2017, which is a continuation of U.S. patent application Ser. No. 14/394,960, filed Oct. 16, 2014, now U.S. Pat. No. 9,780,518 issued Oct. 3, 2017, which is a national phase under 35 U.S.C. § 371 of International Application No. PCT/US2013/032228, filed Mar. 15, 2013, which claims priority to and the benefit of U.S. Provisional Patent Application No. 61/625,961 entitled “Picosecond Laser Apparatus and Methods for Treating Dermal Tissues with Same”, filed Apr. 18, 2012, the entire disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
853033 | Roberts | May 1907 | A |
1590283 | Catlin | Jun 1926 | A |
1676183 | Garfunkle | Jul 1928 | A |
1706161 | Hollnagen | Mar 1929 | A |
2068721 | Wappler et al. | Jan 1937 | A |
2472385 | Rollman | Jun 1949 | A |
2669771 | Burge et al. | Feb 1954 | A |
3243650 | Hawkins et al. | Mar 1966 | A |
3261978 | Brenman | Jul 1966 | A |
3284665 | Goncz | Nov 1966 | A |
3327712 | Kaufmann | Jun 1967 | A |
3465203 | Michaels et al. | Sep 1969 | A |
3486070 | Engel | Dec 1969 | A |
3524144 | Buser et al. | Aug 1970 | A |
3527932 | Thomas | Sep 1970 | A |
3538919 | Meyer | Nov 1970 | A |
3597652 | Gates, Jr. | Aug 1971 | A |
3622743 | Muncheryan | Nov 1971 | A |
3651425 | McKnight | Mar 1972 | A |
3653778 | Freiling | Apr 1972 | A |
3667454 | Prince | Jun 1972 | A |
3693623 | Harte et al. | Sep 1972 | A |
3699967 | Anderson | Oct 1972 | A |
3725733 | Mack et al. | Apr 1973 | A |
3766393 | Herzog et al. | Oct 1973 | A |
3766488 | Kohn | Oct 1973 | A |
3769963 | Goldman et al. | Nov 1973 | A |
3793723 | Kuris et al. | Feb 1974 | A |
3794028 | Mueller et al. | Feb 1974 | A |
3815046 | Johnson et al. | Jun 1974 | A |
3818373 | Chun et al. | Jun 1974 | A |
3818914 | Bender | Jun 1974 | A |
3821510 | Muncheryan | Jun 1974 | A |
3834391 | Block | Sep 1974 | A |
3843865 | Nath | Oct 1974 | A |
3846811 | Nakamura et al. | Nov 1974 | A |
3857015 | Clark et al. | Dec 1974 | A |
3858577 | Bass et al. | Jan 1975 | A |
3861921 | Hoffmann et al. | Jan 1975 | A |
3885569 | Judson | May 1975 | A |
3890537 | Park et al. | Jun 1975 | A |
3900034 | Katz et al. | Aug 1975 | A |
3909649 | Arsena | Sep 1975 | A |
3914709 | Pike et al. | Oct 1975 | A |
3939560 | Lyall | Feb 1976 | A |
3977083 | Leslie et al. | Aug 1976 | A |
3980861 | Fukunaga | Sep 1976 | A |
4019156 | Fountain et al. | Apr 1977 | A |
4037136 | Hoene | Jul 1977 | A |
4038984 | Sittner | Aug 1977 | A |
4047106 | Robinson | Sep 1977 | A |
4065370 | Noble et al. | Dec 1977 | A |
4122853 | Smith | Oct 1978 | A |
4133503 | Bliss | Jan 1979 | A |
4139342 | Sheldrake et al. | Feb 1979 | A |
4154240 | Ikuno et al. | May 1979 | A |
4176324 | Aldag et al. | Nov 1979 | A |
4188927 | Harris | Feb 1980 | A |
4213462 | Sato | Feb 1980 | A |
4228800 | Degler, Jr. et al. | Oct 1980 | A |
4233493 | Nath et al. | Nov 1980 | A |
4254333 | Bergstrom | Mar 1981 | A |
4259123 | Tymkewicz | Mar 1981 | A |
4269067 | Tynan et al. | May 1981 | A |
4273109 | Enderby | Jun 1981 | A |
4275335 | Ishida et al. | Jun 1981 | A |
4291281 | Pinard et al. | Sep 1981 | A |
4292601 | Aldag et al. | Sep 1981 | A |
4293827 | McAllister et al. | Oct 1981 | A |
4298005 | Mutzhas | Nov 1981 | A |
4299912 | Shiba et al. | Nov 1981 | A |
4302730 | Jernigan | Nov 1981 | A |
4313431 | Frank | Feb 1982 | A |
4316467 | Muckerheide | Feb 1982 | A |
4335726 | Kolstedt | May 1982 | A |
4336809 | Clark | May 1982 | A |
4333197 | Kuris | Jun 1982 | A |
4364015 | Drake et al. | Dec 1982 | A |
4375684 | Everett | May 1983 | A |
4388924 | Weissman et al. | Jun 1983 | A |
4409479 | Sprague et al. | Oct 1983 | A |
4428368 | Torii | Jan 1984 | A |
4435808 | Javan | Mar 1984 | A |
4445217 | Acharekar et al. | Apr 1984 | A |
4452081 | Seppi | Jun 1984 | A |
4456872 | Froeschle | Jun 1984 | A |
4461294 | Baron | Jul 1984 | A |
4488104 | Suzuki | Dec 1984 | A |
4489415 | Jones et al. | Dec 1984 | A |
4492601 | Nakasone et al. | Jan 1985 | A |
4503854 | Jako | Mar 1985 | A |
4504727 | Melcher et al. | Mar 1985 | A |
4512197 | von Gutfeld et al. | Apr 1985 | A |
4524289 | Hammond et al. | Jun 1985 | A |
4539987 | Nath et al. | Sep 1985 | A |
4553546 | Javelle | Nov 1985 | A |
4555786 | Byer | Nov 1985 | A |
4556979 | Scott et al. | Dec 1985 | A |
4559943 | Bowers | Dec 1985 | A |
4561440 | Kubo et al. | Dec 1985 | A |
4566271 | French et al. | Jan 1986 | A |
4566438 | Liese et al. | Jan 1986 | A |
4569345 | Manes | Feb 1986 | A |
4576177 | Webster, Jr. | Mar 1986 | A |
4587968 | Price | May 1986 | A |
4591762 | Nakamura | May 1986 | A |
4592353 | Daikuzono | Jun 1986 | A |
4601037 | McDonald | Jul 1986 | A |
4601753 | Soileau et al. | Jul 1986 | A |
4608978 | Rohr | Sep 1986 | A |
4608979 | Breidenthal et al. | Sep 1986 | A |
4617926 | Sutton | Oct 1986 | A |
4623929 | Johnson et al. | Nov 1986 | A |
4629884 | Bergstrom | Dec 1986 | A |
4638800 | Michel | Jan 1987 | A |
4653495 | Nanaumi | Mar 1987 | A |
4656641 | Scifres et al. | Apr 1987 | A |
4662368 | Hussein et al. | May 1987 | A |
4677347 | Nakamura | Jun 1987 | A |
4686986 | Fenyo et al. | Aug 1987 | A |
4693244 | Daikuzono | Sep 1987 | A |
4693556 | McCaughan, Jr. | Sep 1987 | A |
4695697 | Kosa | Sep 1987 | A |
4710677 | Halberstadt et al. | Dec 1987 | A |
4718416 | Nanaumi | Jan 1988 | A |
4724835 | Liss et al. | Feb 1988 | A |
4733660 | Itzkan | Mar 1988 | A |
4735201 | O'Reilly | Apr 1988 | A |
4736743 | Daikuzono | Apr 1988 | A |
4736745 | Gluckman | Apr 1988 | A |
4740047 | Abe et al. | Apr 1988 | A |
4741338 | Miyamae | May 1988 | A |
4745909 | Pelton et al. | May 1988 | A |
4747660 | Nishioka et al. | May 1988 | A |
4749913 | Stuermer et al. | Jun 1988 | A |
4759349 | Betz et al. | Jul 1988 | A |
4773413 | Hussein et al. | Sep 1988 | A |
4775361 | Jacques et al. | Oct 1988 | A |
4779173 | Carr et al. | Oct 1988 | A |
4784135 | Blum et al. | Nov 1988 | A |
4799479 | Spears | Jan 1989 | A |
4813412 | Yamazaki et al. | Mar 1989 | A |
4813762 | Leger et al. | Mar 1989 | A |
4819669 | Politzer | Apr 1989 | A |
4826431 | Fujimura et al. | May 1989 | A |
4829262 | Furumoto | May 1989 | A |
4832024 | Boussignac et al. | May 1989 | A |
4840174 | Gluckman | Jun 1989 | A |
4840563 | Altendorf | Jun 1989 | A |
4845608 | Gdula | Jul 1989 | A |
4848339 | Rink et al. | Jul 1989 | A |
4852107 | Hamal et al. | Jul 1989 | A |
4852549 | Mori | Aug 1989 | A |
4860172 | Schlager et al. | Aug 1989 | A |
4860303 | Russell | Aug 1989 | A |
4860743 | Abela | Aug 1989 | A |
4860744 | Johnson et al. | Aug 1989 | A |
4862886 | Clarke et al. | Sep 1989 | A |
4862888 | Yessik | Sep 1989 | A |
4862903 | Campbell | Sep 1989 | A |
4871479 | Bachelard et al. | Oct 1989 | A |
4878224 | Kuder | Oct 1989 | A |
4884560 | Kuracina | Dec 1989 | A |
4887600 | Watson et al. | Dec 1989 | A |
4889525 | Yuhas et al. | Dec 1989 | A |
4890898 | Bentley et al. | Jan 1990 | A |
4891817 | Duarte | Jan 1990 | A |
4896329 | Knaak | Jan 1990 | A |
4898438 | Mori | Feb 1990 | A |
4898439 | Mori | Feb 1990 | A |
4901323 | Hawkins et al. | Feb 1990 | A |
4905690 | Ohshiro et al. | Mar 1990 | A |
4910438 | Farnsworth | Mar 1990 | A |
4913142 | Kittrell et al. | Apr 1990 | A |
4914298 | Quad et al. | Apr 1990 | A |
4917084 | Sinofsky | Apr 1990 | A |
4926227 | Jensen | May 1990 | A |
4928038 | Nerone | May 1990 | A |
4930504 | Diamantopoulos | Jun 1990 | A |
4931053 | L'Esperance | Jun 1990 | A |
4932954 | Wondrazek et al. | Jun 1990 | A |
4945239 | Wist et al. | Jul 1990 | A |
4950266 | Sinofsky | Aug 1990 | A |
4955882 | Hakky | Sep 1990 | A |
4968314 | Michaels | Nov 1990 | A |
4972427 | Streifer et al. | Nov 1990 | A |
4973848 | Kolobanov et al. | Nov 1990 | A |
4976308 | Faghri | Dec 1990 | A |
4976709 | Sand | Dec 1990 | A |
4977571 | Furumoto et al. | Dec 1990 | A |
4978186 | Mori | Dec 1990 | A |
4979180 | Muncheryan | Dec 1990 | A |
4992256 | Skaggs et al. | Feb 1991 | A |
4994060 | Rink et al. | Feb 1991 | A |
5000752 | Hoskin et al. | Mar 1991 | A |
5006293 | Hartman et al. | Apr 1991 | A |
5009658 | Damgaard-Iversen | Apr 1991 | A |
5011483 | Sleister | Apr 1991 | A |
5027359 | Leger et al. | Jun 1991 | A |
5030090 | Maeda et al. | Jul 1991 | A |
5032178 | Cornell | Jul 1991 | A |
5037421 | Boutacoff et al. | Aug 1991 | A |
5041109 | Abela | Aug 1991 | A |
5046494 | Searfoss et al. | Sep 1991 | A |
5050597 | Daikuzono | Sep 1991 | A |
5056515 | Abel | Oct 1991 | A |
5057099 | Rink | Oct 1991 | A |
5057104 | Chess | Oct 1991 | A |
5059192 | Zaias | Oct 1991 | A |
5060243 | Eckert | Oct 1991 | A |
5061266 | Hakky | Oct 1991 | A |
5065515 | Iderosa | Nov 1991 | A |
5066292 | Müller et al. | Nov 1991 | A |
5066293 | Furumoto | Nov 1991 | A |
5071416 | Heller et al. | Dec 1991 | A |
5071417 | Sinofsky | Dec 1991 | A |
5080660 | Buelna | Jan 1992 | A |
5090019 | Scheps | Feb 1992 | A |
5092865 | Rink | Mar 1992 | A |
5099231 | Sato | Mar 1992 | A |
5102410 | Dressel | Apr 1992 | A |
5108388 | Trokel | Apr 1992 | A |
5109387 | Garden et al. | Apr 1992 | A |
5112328 | Taboada et al. | May 1992 | A |
5127395 | Bontemps | Jul 1992 | A |
5129896 | Hasson | Jul 1992 | A |
5129897 | Daikuzono | Jul 1992 | A |
5132980 | Connors et al. | Jul 1992 | A |
5133102 | Sakuma | Jul 1992 | A |
5137530 | Sand | Aug 1992 | A |
5140608 | Karpol et al. | Aug 1992 | A |
5140984 | Dew et al. | Aug 1992 | A |
5147353 | Everett | Sep 1992 | A |
5147356 | Bhatta | Sep 1992 | A |
5151097 | Daikuzono | Sep 1992 | A |
5159601 | Huber | Oct 1992 | A |
5160194 | Feldman | Nov 1992 | A |
5163935 | Black et al. | Nov 1992 | A |
5171564 | Nathoo et al. | Dec 1992 | A |
5178617 | Kuizenga et al. | Jan 1993 | A |
5180378 | Kung et al. | Jan 1993 | A |
5182557 | Lang | Jan 1993 | A |
5182857 | Simon | Feb 1993 | A |
5190541 | Abele et al. | Mar 1993 | A |
5191883 | Lennox et al. | Mar 1993 | A |
5192278 | Hayes et al. | Mar 1993 | A |
5193526 | Daikuzono | Mar 1993 | A |
5196004 | Sinofsky | Mar 1993 | A |
5197470 | Helfer et al. | Mar 1993 | A |
5201731 | Hakky | Apr 1993 | A |
5207671 | Franken et al. | May 1993 | A |
5207672 | Roth et al. | May 1993 | A |
5207673 | Ebling et al. | May 1993 | A |
5209748 | Daikuzono | May 1993 | A |
5213092 | Uram | May 1993 | A |
5217455 | Tan | Jun 1993 | A |
5219347 | Negus et al. | Jun 1993 | A |
5222907 | Katabuchi et al. | Jun 1993 | A |
5222953 | Dowlatshaki | Jun 1993 | A |
5225926 | Cuomo et al. | Jul 1993 | A |
5226907 | Tankovich | Jul 1993 | A |
5242437 | Everett et al. | Sep 1993 | A |
5242438 | Saadatmanesh | Sep 1993 | A |
5246436 | Rowe | Sep 1993 | A |
5249192 | Kuizenga et al. | Sep 1993 | A |
5254114 | Reed, Jr. et al. | Oct 1993 | A |
5255277 | Carvalho | Oct 1993 | A |
5257970 | Dougherty | Nov 1993 | A |
5257991 | Fletcher et al. | Nov 1993 | A |
5261904 | Baker et al. | Nov 1993 | A |
5267399 | Johnston | Dec 1993 | A |
5267995 | Doiron et al. | Dec 1993 | A |
5267998 | Hagen | Dec 1993 | A |
5269777 | Doiron et al. | Dec 1993 | A |
5269780 | Roos | Dec 1993 | A |
5281211 | Parel et al. | Jan 1994 | A |
5281216 | Klicek | Jan 1994 | A |
5282797 | Chess | Feb 1994 | A |
5284154 | Raymond et al. | Feb 1994 | A |
5287372 | Ortiz | Feb 1994 | A |
5287380 | Hsia | Feb 1994 | A |
5290273 | Tan | Mar 1994 | A |
5290274 | Levy et al. | Mar 1994 | A |
5292320 | Brown et al. | Mar 1994 | A |
5293880 | Levitt | Mar 1994 | A |
5300063 | Tano et al. | Apr 1994 | A |
5300065 | Anderson | Apr 1994 | A |
5300097 | Lerner et al. | Apr 1994 | A |
5303585 | Lichte | Apr 1994 | A |
5304167 | Freiberg | Apr 1994 | A |
5304170 | Green | Apr 1994 | A |
5304173 | Kittrell et al. | Apr 1994 | A |
5306143 | Levy | Apr 1994 | A |
5306274 | Long | Apr 1994 | A |
5307369 | Kimberlin | Apr 1994 | A |
5308311 | Eggers et al. | May 1994 | A |
5312395 | Tan et al. | May 1994 | A |
5312396 | Feld et al. | May 1994 | A |
5320618 | Gustafsson | Jun 1994 | A |
5320620 | Long et al. | Jun 1994 | A |
5330470 | Hagen | Jul 1994 | A |
5331649 | Dacquay et al. | Jul 1994 | A |
5334191 | Poppas et al. | Aug 1994 | A |
5334193 | Nardella | Aug 1994 | A |
5336217 | Buys et al. | Aug 1994 | A |
5336221 | Anderson | Aug 1994 | A |
5342358 | Daikuzono et al. | Aug 1994 | A |
5344418 | Ghaffari | Sep 1994 | A |
5344434 | Talmore | Sep 1994 | A |
5346488 | Prince et al. | Sep 1994 | A |
5348551 | Spears et al. | Sep 1994 | A |
5349590 | Amirkhanian et al. | Sep 1994 | A |
5350376 | Brown | Sep 1994 | A |
5353020 | Schurmann | Oct 1994 | A |
5353790 | Jacques et al. | Oct 1994 | A |
5354294 | Chou | Oct 1994 | A |
5356081 | Sellar | Oct 1994 | A |
5358503 | Bertwell et al. | Oct 1994 | A |
5360426 | Muller et al. | Nov 1994 | A |
5366456 | Rink et al. | Nov 1994 | A |
5368031 | Cline et al. | Nov 1994 | A |
5368038 | Fraden | Nov 1994 | A |
5369496 | Alfano et al. | Nov 1994 | A |
5369831 | Bock | Dec 1994 | A |
5370642 | Keller | Dec 1994 | A |
5370649 | Gardetto et al. | Dec 1994 | A |
5380317 | Everett et al. | Jan 1995 | A |
5383876 | Nardella | Jan 1995 | A |
5386427 | Zayhowski | Jan 1995 | A |
5387211 | Saadatmanesh | Feb 1995 | A |
5395356 | King et al. | Mar 1995 | A |
5403306 | Edwards et al. | Apr 1995 | A |
5405368 | Eckhouse | Apr 1995 | A |
5409446 | Rattner | Apr 1995 | A |
5409479 | Dew et al. | Apr 1995 | A |
5409481 | Poppas et al. | Apr 1995 | A |
5415654 | Daikuzono | May 1995 | A |
5421337 | Richards-Kortum | Jun 1995 | A |
5421339 | Ramanujam et al. | Jun 1995 | A |
5422112 | Williams | Jun 1995 | A |
5423800 | Ren et al. | Jun 1995 | A |
5423803 | Tankovich et al. | Jun 1995 | A |
5423805 | Brucker et al. | Jun 1995 | A |
5425728 | Tankovich | Jun 1995 | A |
5425735 | Rosen et al. | Jun 1995 | A |
5425754 | Braun et al. | Jun 1995 | A |
5439954 | Bush | Aug 1995 | A |
5441499 | Fritzsch | Aug 1995 | A |
5445608 | Chen et al. | Aug 1995 | A |
5445611 | Eppstein et al. | Aug 1995 | A |
5454807 | Lennox et al. | Oct 1995 | A |
5456682 | Edwards et al. | Oct 1995 | A |
5458140 | Eppstein et al. | Oct 1995 | A |
5464436 | Smith | Nov 1995 | A |
5464724 | Akiyama et al. | Nov 1995 | A |
5470331 | Daikuzono | Nov 1995 | A |
5472748 | Wolfe et al. | Dec 1995 | A |
5474549 | Ortiz et al. | Dec 1995 | A |
5484436 | Eggers et al. | Jan 1996 | A |
5486170 | Winston et al. | Jan 1996 | A |
5486172 | Chess | Jan 1996 | A |
5488626 | Heller et al. | Jan 1996 | A |
5489256 | Adair | Feb 1996 | A |
5492894 | Bascom et al. | Feb 1996 | A |
5496305 | Kittrell et al. | Mar 1996 | A |
5496307 | Daikuzono | Mar 1996 | A |
5498935 | McMahan et al. | Mar 1996 | A |
5499313 | Kleinerman | Mar 1996 | A |
5501680 | Kurtz et al. | Mar 1996 | A |
5502582 | Larson et al. | Mar 1996 | A |
5505726 | Meserol | Apr 1996 | A |
5505727 | Keller | Apr 1996 | A |
5507739 | Vassiliadis et al. | Apr 1996 | A |
5519534 | Smith et al. | May 1996 | A |
5521367 | Bard et al. | May 1996 | A |
5522813 | Trelles | Jun 1996 | A |
5527350 | Grove et al. | Jun 1996 | A |
5527368 | Supkis et al. | Jun 1996 | A |
5530711 | Scheps | Jun 1996 | A |
5531739 | Trelles | Jul 1996 | A |
5531740 | Black | Jul 1996 | A |
5536168 | Bourke | Jul 1996 | A |
5540676 | Freiberg | Jul 1996 | A |
5540678 | Long et al. | Jul 1996 | A |
5540681 | Strul et al. | Jul 1996 | A |
5541948 | Krupke et al. | Jul 1996 | A |
5546214 | Black et al. | Aug 1996 | A |
5549660 | Mendes et al. | Aug 1996 | A |
5557625 | Durville | Sep 1996 | A |
5558666 | Dewey et al. | Sep 1996 | A |
5558667 | Yarborough et al. | Sep 1996 | A |
5561881 | Klinger et al. | Oct 1996 | A |
5571098 | Domankevitz et al. | Nov 1996 | A |
5578029 | Trelles et al. | Nov 1996 | A |
5578866 | DePoorter et al. | Nov 1996 | A |
5595568 | Anderson et al. | Jan 1997 | A |
5598426 | Hsia et al. | Jan 1997 | A |
5608210 | Esparza et al. | Mar 1997 | A |
5611793 | Wilson et al. | Mar 1997 | A |
5616140 | Prescott | Apr 1997 | A |
5618284 | Sand | Apr 1997 | A |
5620478 | Eckhouse | Apr 1997 | A |
5624435 | Furumoto et al. | Apr 1997 | A |
5626631 | Eckhouse | May 1997 | A |
5628744 | Coleman et al. | May 1997 | A |
5628771 | Mizukawa et al. | May 1997 | A |
5630811 | Miller | May 1997 | A |
5632741 | Zavislan et al. | May 1997 | A |
5634711 | Kennedy et al. | Jun 1997 | A |
5647866 | Zaias et al. | Jul 1997 | A |
5649972 | Hochstein | Jul 1997 | A |
5651783 | Reynard | Jul 1997 | A |
5652481 | Johnson et al. | Jul 1997 | A |
5653706 | Zavislan et al. | Aug 1997 | A |
5655547 | Karni | Aug 1997 | A |
5657760 | Ying et al. | Aug 1997 | A |
5658148 | Neuberger et al. | Aug 1997 | A |
5658323 | Miller | Aug 1997 | A |
5660836 | Knowlton | Aug 1997 | A |
5661744 | Murakami et al. | Aug 1997 | A |
5662643 | Kung et al. | Sep 1997 | A |
5662644 | Swor | Sep 1997 | A |
5668824 | Furumoto | Sep 1997 | A |
5671315 | Tabuchi et al. | Sep 1997 | A |
5673451 | Moore et al. | Oct 1997 | A |
5679113 | Caisey et al. | Oct 1997 | A |
5683380 | Eckhouse et al. | Nov 1997 | A |
5684902 | Tada | Nov 1997 | A |
5688266 | Edwards et al. | Nov 1997 | A |
5688267 | Panescu et al. | Nov 1997 | A |
5692509 | Voss et al. | Dec 1997 | A |
5698866 | Doiron et al. | Dec 1997 | A |
5707369 | Vaitekunas et al. | Jan 1998 | A |
5707401 | Martin et al. | Jan 1998 | A |
5707403 | Grove et al. | Jan 1998 | A |
5713738 | Yarborough | Feb 1998 | A |
5714119 | Kawagoe et al. | Feb 1998 | A |
5720772 | Eckhouse | Feb 1998 | A |
5722397 | Eppstein | Mar 1998 | A |
5725522 | Sinofsky | Mar 1998 | A |
5728090 | Martin et al. | Mar 1998 | A |
5735844 | Anderson et al. | Apr 1998 | A |
5735884 | Thompson et al. | Apr 1998 | A |
5738678 | Patel | Apr 1998 | A |
5742392 | Anderson et al. | Apr 1998 | A |
5743901 | Grove et al. | Apr 1998 | A |
5743902 | Trost | Apr 1998 | A |
5746735 | Furumoto et al. | May 1998 | A |
5748822 | Miura et al. | May 1998 | A |
5749868 | Furumoto | May 1998 | A |
5755751 | Eckhouse | May 1998 | A |
5759162 | Oppelt et al. | Jun 1998 | A |
5759200 | Azar | Jun 1998 | A |
5760362 | Etoy | Jun 1998 | A |
5769076 | Maekawa et al. | Jun 1998 | A |
5776129 | Mersch | Jul 1998 | A |
5782249 | Weber et al. | Jul 1998 | A |
5802136 | Carol | Sep 1998 | A |
5807386 | Slatkine et al. | Sep 1998 | A |
5810801 | Anderson et al. | Sep 1998 | A |
5810802 | Panescu et al. | Sep 1998 | A |
5812567 | Jeon et al. | Sep 1998 | A |
5813855 | Crisio, Jr. | Sep 1998 | A |
5814008 | Chen et al. | Sep 1998 | A |
5814040 | Nelson et al. | Sep 1998 | A |
5814041 | Anderson et al. | Sep 1998 | A |
5817089 | Tankovich et al. | Oct 1998 | A |
5818580 | Murnick | Oct 1998 | A |
5820625 | Izawa et al. | Oct 1998 | A |
5820626 | Baumgardner | Oct 1998 | A |
5822034 | Shimashita et al. | Oct 1998 | A |
5824023 | Anderson | Oct 1998 | A |
5827264 | Hohla | Oct 1998 | A |
5828803 | Eckhouse | Oct 1998 | A |
5830208 | Muller | Nov 1998 | A |
5830209 | Savage et al. | Nov 1998 | A |
5832931 | Wachter | Nov 1998 | A |
5835648 | Narciso, Jr. | Nov 1998 | A |
5836877 | Zavislan | Nov 1998 | A |
5836999 | Eckhouse et al. | Nov 1998 | A |
5837001 | Mackey | Nov 1998 | A |
5840048 | Cheng | Nov 1998 | A |
5843072 | Furumoto et al. | Dec 1998 | A |
5849029 | Eckhouse et al. | Dec 1998 | A |
5851181 | Talmor | Dec 1998 | A |
5853407 | Miller | Dec 1998 | A |
5860967 | Zavislan et al. | Jan 1999 | A |
5868731 | Budnik et al. | Feb 1999 | A |
5868732 | Waldman et al. | Feb 1999 | A |
5871479 | Furumoto et al. | Feb 1999 | A |
5871480 | Tankovich | Feb 1999 | A |
5879159 | Cipolla | Mar 1999 | A |
5879346 | Waldman et al. | Mar 1999 | A |
5879376 | Miller | Mar 1999 | A |
5883471 | Rodman et al. | Mar 1999 | A |
5885211 | Eppstein et al. | Mar 1999 | A |
5885273 | Eckhouse et al. | Mar 1999 | A |
5885274 | Fullmer et al. | Mar 1999 | A |
5891063 | Vigil | Apr 1999 | A |
5893828 | Uram | Apr 1999 | A |
5893885 | Webster, Jr. | Apr 1999 | A |
5895350 | Hori | Apr 1999 | A |
5897549 | Tankovich | Apr 1999 | A |
5906609 | Assa et al. | May 1999 | A |
5908418 | Dority et al. | Jun 1999 | A |
5908731 | Leenders et al. | Jun 1999 | A |
5913883 | Alexander et al. | Jun 1999 | A |
5916211 | Quon et al. | Jun 1999 | A |
5919601 | Nguyen et al. | Jul 1999 | A |
5920374 | Vaphiades et al. | Jul 1999 | A |
5921926 | Rolland et al. | Jul 1999 | A |
5928222 | Kleinerman | Jul 1999 | A |
5935124 | Klumb et al. | Aug 1999 | A |
5944687 | Benett et al. | Aug 1999 | A |
5944748 | Mager et al. | Aug 1999 | A |
5948011 | Knowlton | Sep 1999 | A |
5948596 | Zhong et al. | Sep 1999 | A |
5949222 | Buono | Sep 1999 | A |
5951543 | Brauer | Sep 1999 | A |
5954710 | Paolini et al. | Sep 1999 | A |
5955490 | Kennedy et al. | Sep 1999 | A |
5957915 | Trost | Sep 1999 | A |
5964749 | Eckhouse et al. | Oct 1999 | A |
5968033 | Fuller et al. | Oct 1999 | A |
5968034 | Fullmer et al. | Oct 1999 | A |
5971976 | Wang et al. | Oct 1999 | A |
5974059 | Dawson | Oct 1999 | A |
5974616 | Dreyfus | Nov 1999 | A |
5976123 | Baumgardner et al. | Nov 1999 | A |
5977723 | Yoon | Nov 1999 | A |
5979454 | Anvari et al. | Nov 1999 | A |
5983900 | Clement et al. | Nov 1999 | A |
5984915 | Loeb et al. | Nov 1999 | A |
6004723 | Figov | Dec 1999 | A |
6007219 | O'Meara | Dec 1999 | A |
6015404 | Altshuler et al. | Jan 2000 | A |
6017677 | Maemoto et al. | Jan 2000 | A |
6022316 | Eppstein et al. | Feb 2000 | A |
6022346 | Panescu et al. | Feb 2000 | A |
6024095 | Stanley, III | Feb 2000 | A |
6026828 | Altshuler | Feb 2000 | A |
6027493 | Donitzky et al. | Feb 2000 | A |
6027495 | Miller | Feb 2000 | A |
6028694 | Schmidt | Feb 2000 | A |
6029303 | Dewan | Feb 2000 | A |
6029304 | Hulke et al. | Feb 2000 | A |
6030378 | Stewart | Feb 2000 | A |
6030399 | Ignotz et al. | Feb 2000 | A |
6032071 | Binder | Feb 2000 | A |
RE36634 | Ghaffari | Mar 2000 | E |
6033431 | Segal | Mar 2000 | A |
6036684 | Tankovich et al. | Mar 2000 | A |
6044514 | Kaneda et al. | Apr 2000 | A |
6045548 | Furumoto et al. | Apr 2000 | A |
6050990 | Tankovich et al. | Apr 2000 | A |
D424197 | Sydlowski et al. | May 2000 | S |
6056548 | Neuberger et al. | May 2000 | A |
6056738 | Marchitto et al. | May 2000 | A |
6058937 | Doiron et al. | May 2000 | A |
6059820 | Baronov | May 2000 | A |
6063108 | Salansky et al. | May 2000 | A |
6068963 | Aoshima | May 2000 | A |
6070092 | Kazama et al. | May 2000 | A |
6071239 | Cribbs et al. | Jun 2000 | A |
6074382 | Asah et al. | Jun 2000 | A |
6077294 | Cho et al. | Jun 2000 | A |
6080146 | Altshuler et al. | Jun 2000 | A |
6080147 | Tobinick | Jun 2000 | A |
6083217 | Tankovich | Jul 2000 | A |
6086363 | Moran et al. | Jul 2000 | A |
6086558 | Bower et al. | Jul 2000 | A |
6086580 | Mordon et al. | Jul 2000 | A |
6090524 | Deboer et al. | Jul 2000 | A |
6132929 | Nakamura | Jul 2000 | A |
6094767 | Iimura | Aug 2000 | A |
6096028 | Bahmanyar et al. | Aug 2000 | A |
6096029 | O'Donnell, Jr. | Aug 2000 | A |
6096209 | O'Brien et al. | Aug 2000 | A |
6099521 | Shadduck | Aug 2000 | A |
6101207 | Ilorinne | Aug 2000 | A |
6104959 | Spertell | Aug 2000 | A |
6106293 | Wiesel | Aug 2000 | A |
6106294 | Daniel | Aug 2000 | A |
6110195 | Xie et al. | Aug 2000 | A |
6112123 | Kelleher et al. | Aug 2000 | A |
6113559 | Klopotek | Sep 2000 | A |
6117129 | Mukai | Sep 2000 | A |
6120497 | Anderson et al. | Sep 2000 | A |
6126655 | Domankevitz et al. | Oct 2000 | A |
6129723 | Anderson | Oct 2000 | A |
6135774 | Hack et al. | Oct 2000 | A |
6142650 | Brown et al. | Nov 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6149644 | Xie | Nov 2000 | A |
6149895 | Kutsch | Nov 2000 | A |
6153352 | Oohashi et al. | Nov 2000 | A |
6159203 | Sinofsky et al. | Dec 2000 | A |
6159236 | Biel | Dec 2000 | A |
6162055 | Montgomery et al. | Dec 2000 | A |
6162211 | Tankovich et al. | Dec 2000 | A |
6162212 | Kreindel et al. | Dec 2000 | A |
6162215 | Feng | Dec 2000 | A |
6162218 | Elbrecht et al. | Dec 2000 | A |
6164837 | Haake et al. | Dec 2000 | A |
6171300 | Adams | Jan 2001 | B1 |
6171301 | Nelson | Jan 2001 | B1 |
6171302 | Talpalriu et al. | Jan 2001 | B1 |
6171332 | Whitehurst | Jan 2001 | B1 |
6173202 | Eppstein | Jan 2001 | B1 |
6174325 | Eckhouse | Jan 2001 | B1 |
6176854 | Cone | Jan 2001 | B1 |
6177230 | Kawamura | Jan 2001 | B1 |
6183434 | Eppstein | Feb 2001 | B1 |
6183500 | Kohler | Feb 2001 | B1 |
6183773 | Anderson | Feb 2001 | B1 |
6187001 | Azar et al. | Feb 2001 | B1 |
6187029 | Shapiro et al. | Feb 2001 | B1 |
6190825 | Denzinger et al. | Feb 2001 | B1 |
6190831 | Leon et al. | Feb 2001 | B1 |
6197020 | O'Donnell, Jr. | Mar 2001 | B1 |
6200134 | Kovac et al. | Mar 2001 | B1 |
6200309 | Rice et al. | Mar 2001 | B1 |
6202242 | Salmon et al. | Mar 2001 | B1 |
6203540 | Weber | Mar 2001 | B1 |
6210425 | Chen | Apr 2001 | B1 |
6210426 | Cho et al. | Apr 2001 | B1 |
6214034 | Azar | Apr 2001 | B1 |
6221068 | Fried et al. | Apr 2001 | B1 |
6221095 | Van Zuylen et al. | Apr 2001 | B1 |
6228074 | Almeida | May 2001 | B1 |
6228075 | Furumoto | May 2001 | B1 |
6229831 | Nightingale et al. | May 2001 | B1 |
6233584 | Purcell et al. | May 2001 | B1 |
6235015 | Mead et al. | May 2001 | B1 |
6235016 | Stewart | May 2001 | B1 |
6236891 | Ingle et al. | May 2001 | B1 |
6238839 | Tomita et al. | May 2001 | B1 |
6239442 | Iimura | May 2001 | B1 |
6240306 | Rohrscheib et al. | May 2001 | B1 |
6240925 | McMillan et al. | Jun 2001 | B1 |
6245093 | Li et al. | Jun 2001 | B1 |
6245486 | Teng | Jun 2001 | B1 |
6246710 | Furumoto | Jun 2001 | B1 |
6246740 | Maruyama et al. | Jun 2001 | B1 |
6248103 | Tannenbaum et al. | Jun 2001 | B1 |
6248503 | Vermeersch et al. | Jun 2001 | B1 |
6251127 | Biel | Jun 2001 | B1 |
6254388 | Yarborough | Jul 2001 | B1 |
6263233 | Zavislan et al. | Jul 2001 | B1 |
6264649 | Whitcroft et al. | Jul 2001 | B1 |
6267779 | Gerdes | Jul 2001 | B1 |
6267780 | Streeter | Jul 2001 | B1 |
6273883 | Furumoto | Aug 2001 | B1 |
6273884 | Altshuler et al. | Aug 2001 | B1 |
6273885 | Koop et al. | Aug 2001 | B1 |
6280438 | Eckhouse et al. | Aug 2001 | B1 |
6282442 | Destefano et al. | Aug 2001 | B1 |
6283956 | McDaniel | Sep 2001 | B1 |
6287549 | Sumian et al. | Sep 2001 | B1 |
6290496 | Azar et al. | Sep 2001 | B1 |
6290712 | Nordquist et al. | Sep 2001 | B1 |
6290713 | Russell | Sep 2001 | B1 |
6294311 | Shimazu et al. | Sep 2001 | B1 |
6306130 | Anderson et al. | Oct 2001 | B1 |
6306160 | Nidetzky | Oct 2001 | B1 |
6315772 | Marchitto et al. | Nov 2001 | B1 |
6317624 | Kollias et al. | Nov 2001 | B1 |
6319274 | Shadduck | Nov 2001 | B1 |
6322584 | Ingle et al. | Nov 2001 | B2 |
6325769 | Klopotek | Dec 2001 | B1 |
6327506 | Yogo et al. | Dec 2001 | B1 |
6328733 | Trost | Dec 2001 | B1 |
6331111 | Cao | Dec 2001 | B1 |
6332891 | Himes | Dec 2001 | B1 |
6338855 | Albacarys et al. | Jan 2002 | B1 |
6340495 | Sumian et al. | Jan 2002 | B1 |
6343400 | Massholder et al. | Feb 2002 | B1 |
6343933 | Montgomery et al. | Feb 2002 | B1 |
6346365 | Kawauchi et al. | Feb 2002 | B1 |
6350261 | Domankevitz et al. | Feb 2002 | B1 |
6350276 | Knowlton | Feb 2002 | B1 |
6352811 | Patel et al. | Mar 2002 | B1 |
6354370 | Miller et al. | Mar 2002 | B1 |
6355054 | Neuberger | Mar 2002 | B1 |
6358242 | Cecchetti | Mar 2002 | B1 |
6358272 | Wilden | Mar 2002 | B1 |
6358669 | Savariar-Hauck et al. | Mar 2002 | B1 |
6364872 | Hsia et al. | Apr 2002 | B1 |
6383176 | Connors et al. | May 2002 | B1 |
6383177 | Balle-Petersen | May 2002 | B1 |
6387089 | Kreindel et al. | May 2002 | B1 |
6387353 | Jensen et al. | May 2002 | B1 |
6391022 | Furumoto et al. | May 2002 | B1 |
6394949 | Crowley et al. | May 2002 | B1 |
6395016 | Oron et al. | May 2002 | B1 |
6398801 | Clement et al. | Jun 2002 | B1 |
6400011 | Miki | Jun 2002 | B1 |
6402739 | Neev | Jun 2002 | B1 |
6405732 | Edwards et al. | Jun 2002 | B1 |
6406474 | Neuberger et al. | Jun 2002 | B1 |
6409665 | Scott et al. | Jun 2002 | B1 |
6409723 | Edwards | Jun 2002 | B1 |
6413267 | Dumoulin-White | Jul 2002 | B1 |
6416319 | Cipolla | Jul 2002 | B1 |
6419389 | Fuchs et al. | Jul 2002 | B1 |
6423462 | Kunita | Jul 2002 | B1 |
6424852 | Zavislan | Jul 2002 | B1 |
6425912 | Knowlton | Jul 2002 | B1 |
6435873 | Burgio | Aug 2002 | B1 |
6436094 | Reuter | Aug 2002 | B1 |
6439888 | Boutoussov et al. | Aug 2002 | B1 |
6440155 | Matsumae et al. | Aug 2002 | B1 |
6440633 | Kawauchi | Aug 2002 | B1 |
6443946 | Clement et al. | Sep 2002 | B2 |
6443978 | Zharov | Sep 2002 | B1 |
6447503 | Wynne et al. | Sep 2002 | B1 |
6447504 | Ben-Haim et al. | Sep 2002 | B1 |
6451007 | Koop et al. | Sep 2002 | B1 |
6454790 | Neuberger et al. | Sep 2002 | B1 |
6459919 | Lys et al. | Oct 2002 | B1 |
6461296 | Desai | Oct 2002 | B1 |
6464694 | Massengill | Oct 2002 | B1 |
6468717 | Kita et al. | Oct 2002 | B2 |
6470216 | Mulholland | Oct 2002 | B1 |
6471712 | Burres | Oct 2002 | B2 |
6471716 | Pecukonis | Oct 2002 | B1 |
6475211 | Chess et al. | Nov 2002 | B2 |
6482199 | Neev | Nov 2002 | B1 |
6484052 | Visuri et al. | Nov 2002 | B1 |
6485413 | Boppart et al. | Nov 2002 | B1 |
6491685 | Visuri et al. | Dec 2002 | B2 |
6493608 | Niemeyer | Dec 2002 | B1 |
6494900 | Salansky et al. | Dec 2002 | B1 |
6497702 | Bernaz | Dec 2002 | B1 |
6503269 | Nield et al. | Jan 2003 | B2 |
6503486 | Xu et al. | Jan 2003 | B2 |
6508785 | Eppstein | Jan 2003 | B1 |
6508813 | Altshuler | Jan 2003 | B1 |
6511475 | Altshuler et al. | Jan 2003 | B1 |
6514243 | Eckhouse et al. | Feb 2003 | B1 |
6517532 | Altshuler et al. | Feb 2003 | B1 |
6519376 | Biagi et al. | Feb 2003 | B2 |
6525819 | Delawter et al. | Feb 2003 | B1 |
6527716 | Eppstein | Mar 2003 | B1 |
6527764 | Neuberger et al. | Mar 2003 | B1 |
6529540 | Demmer et al. | Mar 2003 | B1 |
6530915 | Eppstein et al. | Mar 2003 | B1 |
6530916 | Shimmick | Mar 2003 | B1 |
6537270 | Elbrecht et al. | Mar 2003 | B1 |
6544257 | Nagage et al. | Apr 2003 | B2 |
6547780 | Sinofsky | Apr 2003 | B1 |
6551346 | Crossley | Apr 2003 | B2 |
6554439 | Teicher et al. | Apr 2003 | B1 |
6556596 | Kim et al. | Apr 2003 | B1 |
6558372 | Altshuler | May 2003 | B1 |
6561808 | Neuberger | May 2003 | B2 |
6569155 | Connors et al. | May 2003 | B1 |
6570892 | Lin et al. | May 2003 | B1 |
6570893 | Libatique et al. | May 2003 | B1 |
6572634 | Koo | Jun 2003 | B2 |
6572637 | Yamazaki et al. | Jun 2003 | B1 |
6595934 | Hissong et al. | Jul 2003 | B1 |
6600951 | Anderson | Jul 2003 | B1 |
6602245 | Thiberg | Aug 2003 | B1 |
6602275 | Sullivan | Aug 2003 | B1 |
6603988 | Dowlatshahi | Aug 2003 | B2 |
6605080 | Altshuler et al. | Aug 2003 | B1 |
6605083 | Clement et al. | Aug 2003 | B2 |
6606755 | Robinson et al. | Aug 2003 | B1 |
6607525 | France et al. | Aug 2003 | B2 |
6610052 | Furumoto | Aug 2003 | B2 |
6613040 | Tankovich et al. | Sep 2003 | B2 |
6616447 | Rizoiu et al. | Sep 2003 | B1 |
6616451 | Rizoiu et al. | Sep 2003 | B1 |
6618531 | Goto et al. | Sep 2003 | B1 |
6623272 | Clemans | Sep 2003 | B2 |
6623513 | Biel | Sep 2003 | B2 |
6629971 | McDaniel | Oct 2003 | B2 |
6629989 | Akita | Oct 2003 | B2 |
6632219 | Baranov et al. | Oct 2003 | B1 |
6635075 | Li et al. | Oct 2003 | B2 |
6641578 | Mukai | Nov 2003 | B2 |
6641600 | Kohler | Nov 2003 | B1 |
6648904 | Altshuler et al. | Nov 2003 | B2 |
6652459 | Payne et al. | Nov 2003 | B2 |
6653618 | Zenzie | Nov 2003 | B2 |
6659999 | Anderson et al. | Dec 2003 | B1 |
6660000 | Neuberger et al. | Dec 2003 | B2 |
6663620 | Altshuler et al. | Dec 2003 | B2 |
6663658 | Kollias et al. | Dec 2003 | B1 |
6663659 | McDaniel | Dec 2003 | B2 |
6666856 | Connors et al. | Dec 2003 | B2 |
6669685 | Rizoiu et al. | Dec 2003 | B1 |
6675425 | Iimura | Jan 2004 | B1 |
6676654 | Balle-Petersen | Jan 2004 | B1 |
6679837 | Daikuzono | Jan 2004 | B2 |
6682523 | Shadduck | Jan 2004 | B2 |
6682524 | Elbrecht et al. | Jan 2004 | B1 |
6685639 | Wang et al. | Feb 2004 | B1 |
6685699 | Eppstein et al. | Feb 2004 | B1 |
6685722 | Rosenbluth et al. | Feb 2004 | B1 |
6689124 | Thiberg | Feb 2004 | B1 |
6692456 | Eppstein et al. | Feb 2004 | B1 |
6692517 | Cho et al. | Feb 2004 | B2 |
6699040 | Hahn et al. | Mar 2004 | B1 |
6706035 | Cense et al. | Mar 2004 | B2 |
6709269 | Altshuler | Mar 2004 | B1 |
6709446 | Lundahl et al. | Mar 2004 | B2 |
6723090 | Altshuler et al. | Apr 2004 | B2 |
6724958 | German et al. | Apr 2004 | B1 |
6726681 | Grasso et al. | Apr 2004 | B2 |
6736807 | Yamazaki et al. | May 2004 | B2 |
6743222 | Durkin et al. | Jun 2004 | B2 |
6746444 | Key | Jun 2004 | B2 |
6749623 | Hsi et al. | Jun 2004 | B1 |
6755647 | Melikechi et al. | Jun 2004 | B2 |
6770069 | Hobart et al. | Aug 2004 | B1 |
6772053 | Niemeyer | Aug 2004 | B2 |
6790205 | Yamazaki et al. | Sep 2004 | B1 |
6800122 | Anderson et al. | Oct 2004 | B2 |
6801595 | Grodzins et al. | Oct 2004 | B2 |
6808331 | Hall et al. | Oct 2004 | B2 |
6808532 | Andersen et al. | Oct 2004 | B2 |
6824542 | Jay | Nov 2004 | B2 |
RE38670 | Asah et al. | Dec 2004 | E |
6858009 | Kawata et al. | Feb 2005 | B2 |
6860879 | Irion et al. | Mar 2005 | B2 |
6860896 | Leber et al. | Mar 2005 | B2 |
6862771 | Muller | Mar 2005 | B1 |
6863781 | Nocera et al. | Mar 2005 | B2 |
6872203 | Shafirstein et al. | Mar 2005 | B2 |
6878144 | Altshuler et al. | Apr 2005 | B2 |
6881212 | Clement et al. | Apr 2005 | B1 |
6887260 | McDaniel | May 2005 | B1 |
6888319 | Inochkin et al. | May 2005 | B2 |
6893259 | Reizenson | May 2005 | B1 |
6902397 | Farrell et al. | Jun 2005 | B2 |
6902563 | Wilkens et al. | Jun 2005 | B2 |
6905492 | Zvuloni et al. | Jun 2005 | B2 |
6916316 | Jay | Jul 2005 | B2 |
6917715 | Berstis et al. | Jul 2005 | B2 |
6936046 | Hissong et al. | Aug 2005 | B2 |
6942658 | Rizoiu et al. | Sep 2005 | B1 |
6953341 | Black | Oct 2005 | B2 |
6974450 | Weber et al. | Dec 2005 | B2 |
6974451 | Altshuler et al. | Dec 2005 | B2 |
6976985 | Altshuler et al. | Dec 2005 | B2 |
6986903 | Zulli et al. | Jan 2006 | B2 |
6989007 | Shadduck | Jan 2006 | B2 |
6989023 | Black | Jan 2006 | B2 |
6991644 | Spooner et al. | Jan 2006 | B2 |
6997923 | Anderson et al. | Feb 2006 | B2 |
7001413 | Butler | Feb 2006 | B2 |
7006223 | Mullani | Feb 2006 | B2 |
7006874 | Knowlton | Feb 2006 | B2 |
7018196 | Sierra et al. | Mar 2006 | B2 |
7029469 | Vasily | Apr 2006 | B2 |
7033349 | Key | Apr 2006 | B2 |
7041094 | Connors et al. | May 2006 | B2 |
7041100 | Kreindel | May 2006 | B2 |
7044959 | Anderson et al. | May 2006 | B2 |
7060061 | Altshuler et al. | Jun 2006 | B2 |
7066733 | Logan et al. | Jun 2006 | B2 |
7070611 | Biel | Jul 2006 | B2 |
7077840 | Altshuler et al. | Jul 2006 | B2 |
7081128 | Hart et al. | Jul 2006 | B2 |
7097639 | Almeida | Aug 2006 | B1 |
7097656 | Akopov et al. | Aug 2006 | B1 |
7104985 | Martinelli | Sep 2006 | B2 |
7118562 | Furumoto | Oct 2006 | B2 |
7118563 | Weckwerth et al. | Oct 2006 | B2 |
7135033 | Altshuler et al. | Nov 2006 | B2 |
7144247 | Black | Dec 2006 | B2 |
7144248 | Irwin | Dec 2006 | B2 |
7145105 | Gaulard | Dec 2006 | B2 |
7145108 | Kanel et al. | Dec 2006 | B2 |
7160289 | Cohen | Jan 2007 | B2 |
7170034 | Shalev | Jan 2007 | B2 |
7175617 | Jay | Feb 2007 | B2 |
7182760 | Kubota | Feb 2007 | B2 |
7198634 | Harth et al. | Apr 2007 | B2 |
7202446 | Shalev | Apr 2007 | B2 |
7204832 | Altshuler et al. | Apr 2007 | B2 |
7216055 | Horton et al. | May 2007 | B1 |
7217265 | Hennings et al. | May 2007 | B2 |
7217267 | Jay | May 2007 | B2 |
7220254 | Altshuler et al. | May 2007 | B2 |
7223270 | Altshuler et al. | May 2007 | B2 |
7223281 | Altshuler et al. | May 2007 | B2 |
7255691 | Tolkoff et al. | Aug 2007 | B2 |
7274155 | Inochkin et al. | Sep 2007 | B2 |
7276058 | Altshuler et al. | Oct 2007 | B2 |
7280866 | McIntosh et al. | Oct 2007 | B1 |
7282060 | DeBenedictis | Oct 2007 | B2 |
7282723 | Schomaket et al. | Oct 2007 | B2 |
7291140 | MacFarland et al. | Nov 2007 | B2 |
7291141 | Harvey | Nov 2007 | B2 |
7309335 | Altshuler et al. | Dec 2007 | B2 |
7311722 | Larsen | Dec 2007 | B2 |
7322972 | Viator et al. | Jan 2008 | B2 |
7329273 | Altshuler et al. | Feb 2008 | B2 |
7329274 | Altshuler et al. | Feb 2008 | B2 |
7331953 | Manstein et al. | Feb 2008 | B2 |
7331964 | Maricle et al. | Feb 2008 | B2 |
7333698 | Israel | Feb 2008 | B2 |
7333841 | Maruo et al. | Feb 2008 | B2 |
7351252 | Altshuler et al. | Apr 2008 | B2 |
7354448 | Altshuler et al. | Apr 2008 | B2 |
7422598 | Altshuler et al. | Sep 2008 | B2 |
7423767 | Steinsiek et al. | Sep 2008 | B2 |
7431719 | Altshuler | Oct 2008 | B2 |
7436863 | Matsuda et al. | Oct 2008 | B2 |
7500956 | Wilk | Mar 2009 | B1 |
7531967 | Inochkin et al. | May 2009 | B2 |
7540869 | Altshuler et al. | Jun 2009 | B2 |
7553308 | Jay | Jun 2009 | B2 |
7586957 | Sierra et al. | Sep 2009 | B2 |
7588547 | Deem et al. | Sep 2009 | B2 |
7624640 | Maris et al. | Dec 2009 | B2 |
7647092 | Motz et al. | Jan 2010 | B2 |
7699058 | Jay | Apr 2010 | B1 |
7722600 | Connors et al. | May 2010 | B2 |
7758621 | Altshuler et al. | Jul 2010 | B2 |
7763016 | Altshuler et al. | Jul 2010 | B2 |
7839972 | Ruchala et al. | Nov 2010 | B2 |
7856985 | Mirkov | Dec 2010 | B2 |
7860554 | Leonardi | Dec 2010 | B2 |
7929579 | Hohm et al. | Apr 2011 | B2 |
7931028 | Jay | Apr 2011 | B2 |
7935107 | Altshuler et al. | May 2011 | B2 |
7938821 | Chan et al. | May 2011 | B2 |
7942869 | Houbolt et al. | May 2011 | B2 |
7942915 | Altshuler et al. | May 2011 | B2 |
7942916 | Altshuler et al. | May 2011 | B2 |
7998181 | Nightingale et al. | Aug 2011 | B2 |
8002768 | Altshuler et al. | Aug 2011 | B1 |
8027710 | Dannan | Sep 2011 | B1 |
8109924 | Altshuler | Feb 2012 | B2 |
8113209 | Masotti et al. | Feb 2012 | B2 |
8182473 | Altshuler et al. | May 2012 | B2 |
8317779 | Mirkov et al. | Nov 2012 | B2 |
8322348 | Mirkov et al. | Dec 2012 | B2 |
8328794 | Altshuler et al. | Dec 2012 | B2 |
8328796 | Altshuler et al. | Dec 2012 | B2 |
8346347 | Altshuler et al. | Jan 2013 | B2 |
8357145 | Hennings et al. | Jan 2013 | B2 |
8378322 | Dahm et al. | Feb 2013 | B2 |
8439940 | Chomas et al. | May 2013 | B2 |
9028536 | Sierra et al. | May 2015 | B2 |
9066736 | Islam | Jun 2015 | B2 |
20010007068 | Ota | Jul 2001 | A1 |
20010008973 | Van Zuylen et al. | Jul 2001 | A1 |
20010016732 | Hobart et al. | Aug 2001 | A1 |
20010023363 | Harth et al. | Sep 2001 | A1 |
20010024777 | Azar et al. | Sep 2001 | A1 |
20010025173 | Ritchie et al. | Sep 2001 | A1 |
20010029956 | Argenta et al. | Oct 2001 | A1 |
20010041886 | Durkin et al. | Nov 2001 | A1 |
20010046652 | Ostler et al. | Nov 2001 | A1 |
20010048077 | Afanassieva | Dec 2001 | A1 |
20020002367 | Tankovich et al. | Jan 2002 | A1 |
20020004066 | Stanley et al. | Jan 2002 | A1 |
20020005475 | Zenzie | Jan 2002 | A1 |
20020013572 | Berlin | Jan 2002 | A1 |
20020015911 | Nakamura | Feb 2002 | A1 |
20020016587 | Furumoto | Feb 2002 | A1 |
20020018754 | Sagel et al. | Feb 2002 | A1 |
20020019624 | Clement et al. | Feb 2002 | A1 |
20020019625 | Azar | Feb 2002 | A1 |
20020026225 | Segal | Feb 2002 | A1 |
20020028404 | Nakamura | Mar 2002 | A1 |
20020029071 | Whitehurst | Mar 2002 | A1 |
20020032437 | Andrews et al. | Mar 2002 | A1 |
20020039702 | Hotta | Apr 2002 | A1 |
20020045891 | Clement et al. | Apr 2002 | A1 |
20020048722 | Aoshima | Apr 2002 | A1 |
20020049432 | Mukai | Apr 2002 | A1 |
20020049483 | Knowlton | Apr 2002 | A1 |
20020058890 | Visuri et al. | May 2002 | A1 |
20020071287 | Haase | Jun 2002 | A1 |
20020071827 | Petersen et al. | Jun 2002 | A1 |
20020072676 | Afanassieva | Jun 2002 | A1 |
20020081555 | Wiesel | Jun 2002 | A1 |
20020090725 | Simpson et al. | Jul 2002 | A1 |
20020091377 | Anderson et al. | Jul 2002 | A1 |
20020108193 | Gruber | Aug 2002 | A1 |
20020111546 | Cook et al. | Aug 2002 | A1 |
20020111610 | Nordquist | Aug 2002 | A1 |
20020120256 | Furuno et al. | Aug 2002 | A1 |
20020123745 | Svaasand et al. | Sep 2002 | A1 |
20020125230 | Haight et al. | Sep 2002 | A1 |
20020127224 | Chen | Sep 2002 | A1 |
20020128635 | Altshuler et al. | Sep 2002 | A1 |
20020128695 | Harth et al. | Sep 2002 | A1 |
20020128696 | Pearl | Sep 2002 | A1 |
20020151878 | Shimmick et al. | Oct 2002 | A1 |
20020151879 | Loeb | Oct 2002 | A1 |
20020160299 | Asawa et al. | Oct 2002 | A1 |
20020161357 | Anderson et al. | Oct 2002 | A1 |
20020161418 | Wilkens et al. | Oct 2002 | A1 |
20020167974 | Kennedy et al. | Nov 2002 | A1 |
20020173723 | Lewis | Nov 2002 | A1 |
20020173777 | Sand | Nov 2002 | A1 |
20020173780 | Altshuler et al. | Nov 2002 | A1 |
20020173781 | Cense et al. | Nov 2002 | A1 |
20020173782 | Cense et al. | Nov 2002 | A1 |
20020182563 | Boutoussov et al. | Dec 2002 | A1 |
20020183808 | Biel | Dec 2002 | A1 |
20020198517 | Alfano et al. | Dec 2002 | A1 |
20030004499 | McDaniel | Jan 2003 | A1 |
20030009158 | Perricone | Jan 2003 | A1 |
20030009205 | Biel | Jan 2003 | A1 |
20030018373 | Eckhardt et al. | Jan 2003 | A1 |
20030023235 | Cense et al. | Jan 2003 | A1 |
20030023283 | McDaniel | Jan 2003 | A1 |
20030023284 | Gartstein et al. | Jan 2003 | A1 |
20030028186 | Kreintel | Feb 2003 | A1 |
20030028227 | Neuberger et al. | Feb 2003 | A1 |
20030032900 | Ella | Feb 2003 | A1 |
20030032950 | Altshuler et al. | Feb 2003 | A1 |
20030036680 | Black | Feb 2003 | A1 |
20030040739 | Koop | Feb 2003 | A1 |
20030055413 | Altshuler et al. | Mar 2003 | A1 |
20030055414 | Altshuler et al. | Mar 2003 | A1 |
20030057875 | Inochkin et al. | Mar 2003 | A1 |
20030059738 | Neuberger | Mar 2003 | A1 |
20030065314 | Altshuler et al. | Apr 2003 | A1 |
20030073989 | Hoey et al. | Apr 2003 | A1 |
20030083649 | Margaron et al. | May 2003 | A1 |
20030084534 | Kaizuka | May 2003 | A1 |
20030092982 | Eppstein | May 2003 | A1 |
20030097122 | Ganz et al. | May 2003 | A1 |
20030100936 | Altshuler et al. | May 2003 | A1 |
20030104340 | Clemans | Jun 2003 | A1 |
20030109787 | Black | Jun 2003 | A1 |
20030109860 | Black | Jun 2003 | A1 |
20030113684 | Scott | Jun 2003 | A1 |
20030129154 | McDaniel | Jul 2003 | A1 |
20030130709 | Haber | Jul 2003 | A1 |
20030152528 | Singh et al. | Aug 2003 | A1 |
20030158550 | Ganz et al. | Aug 2003 | A1 |
20030163884 | Weihrauch | Sep 2003 | A1 |
20030167080 | Hart et al. | Sep 2003 | A1 |
20030169433 | Koele et al. | Sep 2003 | A1 |
20030181896 | Zvuloni et al. | Sep 2003 | A1 |
20030187319 | Kaneko | Oct 2003 | A1 |
20030187383 | Weber et al. | Oct 2003 | A1 |
20030187486 | Savage et al. | Oct 2003 | A1 |
20030195494 | Altshuler et al. | Oct 2003 | A1 |
20030199859 | Altshuler et al. | Oct 2003 | A1 |
20030216719 | DeBenedictis | Nov 2003 | A1 |
20030216795 | Harth et al. | Nov 2003 | A1 |
20030232303 | Black | Dec 2003 | A1 |
20030233138 | Spooner | Dec 2003 | A1 |
20040006332 | Black | Jan 2004 | A1 |
20040010298 | Altshuler et al. | Jan 2004 | A1 |
20040015156 | Vasily | Jan 2004 | A1 |
20040015158 | Chen et al. | Jan 2004 | A1 |
20040019120 | Vargas et al. | Jan 2004 | A1 |
20040019990 | Farrell et al. | Feb 2004 | A1 |
20040024388 | Altshuler | Feb 2004 | A1 |
20040024430 | Bader et al. | Feb 2004 | A1 |
20040030326 | Altshuler et al. | Feb 2004 | A1 |
20040034319 | Anderson et al. | Feb 2004 | A1 |
20040034341 | Altshuler et al. | Feb 2004 | A1 |
20040036975 | Slatkine | Feb 2004 | A1 |
20040054248 | Kimchy et al. | Mar 2004 | A1 |
20040073079 | Altshuler et al. | Apr 2004 | A1 |
20040082940 | Black et al. | Apr 2004 | A1 |
20040085026 | Inochkin et al. | May 2004 | A1 |
20040092506 | Thompson et al. | May 2004 | A1 |
20040093042 | Altshuler et al. | May 2004 | A1 |
20040093043 | Edel et al. | May 2004 | A1 |
20040098070 | Mohr et al. | May 2004 | A1 |
20040105611 | Bischel et al. | Jun 2004 | A1 |
20040111031 | Alfano et al. | Jun 2004 | A1 |
20040111086 | Trombly | Jun 2004 | A1 |
20040111132 | Shenderova et al. | Jun 2004 | A1 |
20040116984 | Spooner et al. | Jun 2004 | A1 |
20040122311 | Cosman | Jun 2004 | A1 |
20040133251 | Altshuler et al. | Jul 2004 | A1 |
20040143181 | Damasio et al. | Jul 2004 | A1 |
20040143247 | Anderson et al. | Jul 2004 | A1 |
20040143920 | Nanda | Jul 2004 | A1 |
20040147984 | Altshuler et al. | Jul 2004 | A1 |
20040156626 | Thoms | Aug 2004 | A1 |
20040161213 | Lee | Aug 2004 | A1 |
20040162490 | Soltz et al. | Aug 2004 | A1 |
20040162549 | Altshuler | Aug 2004 | A1 |
20040162596 | Altshuler et al. | Aug 2004 | A1 |
20040167502 | Weckwerth et al. | Aug 2004 | A1 |
20040176754 | Island et al. | Sep 2004 | A1 |
20040176764 | Dant | Sep 2004 | A1 |
20040186465 | Francischelli | Sep 2004 | A1 |
20040191729 | Altshuler et al. | Sep 2004 | A1 |
20040193234 | Butler | Sep 2004 | A1 |
20040193235 | Altshuler et al. | Sep 2004 | A1 |
20040193236 | Altshuler et al. | Sep 2004 | A1 |
20040199079 | Chuck et al. | Oct 2004 | A1 |
20040199151 | Neuberger | Oct 2004 | A1 |
20040199227 | Altshuler et al. | Oct 2004 | A1 |
20040204745 | Altshuler et al. | Oct 2004 | A1 |
20040208918 | Koch et al. | Oct 2004 | A1 |
20040210275 | Town et al. | Oct 2004 | A1 |
20040210276 | Altshuler et al. | Oct 2004 | A1 |
20040214132 | Altshuler | Oct 2004 | A1 |
20040225339 | Yaroslavsky et al. | Nov 2004 | A1 |
20040230258 | Altshuler et al. | Nov 2004 | A1 |
20040230260 | MacFarland et al. | Nov 2004 | A1 |
20040234460 | Tarver et al. | Nov 2004 | A1 |
20040249261 | Torchia et al. | Dec 2004 | A1 |
20040260210 | Ella et al. | Dec 2004 | A1 |
20050015077 | Kuklin et al. | Jan 2005 | A1 |
20050038418 | Altshuler et al. | Feb 2005 | A1 |
20050049467 | Stamatas et al. | Mar 2005 | A1 |
20050049582 | DeBenedictis et al. | Mar 2005 | A1 |
20050049658 | Connors et al. | Mar 2005 | A1 |
20050063931 | Paus et al. | Mar 2005 | A1 |
20050065502 | Stoltz | Mar 2005 | A1 |
20050065531 | Cohen | Mar 2005 | A1 |
20050074038 | Khaydarov | Apr 2005 | A1 |
20050080404 | Jones et al. | Apr 2005 | A1 |
20050085875 | Van Zuylen | Apr 2005 | A1 |
20050102213 | Savasoglu et al. | May 2005 | A1 |
20050107849 | Altshuler et al. | May 2005 | A1 |
20050113815 | Ritchie et al. | May 2005 | A1 |
20050113890 | Ritchie et al. | May 2005 | A1 |
20050116673 | Carl et al. | Jun 2005 | A1 |
20050131400 | Hennings et al. | Jun 2005 | A1 |
20050143719 | Sink | Jun 2005 | A1 |
20050143723 | Zvuloni et al. | Jun 2005 | A1 |
20050154380 | DeBenedictis | Jul 2005 | A1 |
20050165315 | Zuluaga et al. | Jul 2005 | A1 |
20050165393 | Eppstein | Jul 2005 | A1 |
20050168158 | Inochkin et al. | Aug 2005 | A1 |
20050170313 | Pitz et al. | Aug 2005 | A1 |
20050171517 | Altshuler et al. | Aug 2005 | A1 |
20050171581 | Connors et al. | Aug 2005 | A1 |
20050177026 | Hoeg et al. | Aug 2005 | A1 |
20050177139 | Yamazaki et al. | Aug 2005 | A1 |
20050177142 | Jay | Aug 2005 | A1 |
20050182389 | Laporte et al. | Aug 2005 | A1 |
20050197681 | Barolet et al. | Sep 2005 | A1 |
20050203496 | Ritchie et al. | Sep 2005 | A1 |
20050203497 | Speeg et al. | Sep 2005 | A1 |
20050215988 | Altshuler et al. | Sep 2005 | A1 |
20050220726 | Pauly et al. | Oct 2005 | A1 |
20050222556 | Arivra et al. | Oct 2005 | A1 |
20050245917 | Strassl et al. | Nov 2005 | A1 |
20050251116 | Steinke et al. | Nov 2005 | A1 |
20050251117 | Anderson et al. | Nov 2005 | A1 |
20050251118 | Anderson et al. | Nov 2005 | A1 |
20050251120 | Anderson et al. | Nov 2005 | A1 |
20050257612 | Hiemer et al. | Nov 2005 | A1 |
20050281530 | Rizoiu et al. | Dec 2005 | A1 |
20060004306 | Altshuler et al. | Jan 2006 | A1 |
20060004347 | Altshuler et al. | Jan 2006 | A1 |
20060007965 | Tankovich et al. | Jan 2006 | A1 |
20060009750 | Altshuler et al. | Jan 2006 | A1 |
20060013533 | Slatkine et al. | Jan 2006 | A1 |
20060020309 | Altshuler et al. | Jan 2006 | A1 |
20060047281 | Kreindel et al. | Mar 2006 | A1 |
20060052661 | Gannot et al. | Mar 2006 | A1 |
20060056589 | Engelward | Mar 2006 | A1 |
20060058712 | Altshuler et al. | Mar 2006 | A1 |
20060062448 | Hirsch et al. | Mar 2006 | A1 |
20060079947 | Tankovich et al. | Apr 2006 | A1 |
20060089687 | Spooner et al. | Apr 2006 | A1 |
20060094988 | Tosaya et al. | May 2006 | A1 |
20060100677 | Blumenkranz et al. | May 2006 | A1 |
20060116671 | Slayton et al. | Jun 2006 | A1 |
20060118127 | Chinn | Jun 2006 | A1 |
20060122584 | Bommannan et al. | Jun 2006 | A1 |
20060122668 | Anderson et al. | Jun 2006 | A1 |
20060128771 | Mirkov et al. | Jun 2006 | A1 |
20060149343 | Altshuler et al. | Jul 2006 | A1 |
20060155266 | Manstein et al. | Jul 2006 | A1 |
20060161143 | Altshuler et al. | Jul 2006 | A1 |
20060173480 | Zhang | Aug 2006 | A1 |
20060194164 | Altshuler et al. | Aug 2006 | A1 |
20060206103 | Altshuler et al. | Sep 2006 | A1 |
20060217689 | Dick et al. | Sep 2006 | A1 |
20060224148 | Cho et al. | Oct 2006 | A1 |
20060247609 | Mirkov et al. | Nov 2006 | A1 |
20060253176 | Caruso et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060265032 | Hennings | Nov 2006 | A1 |
20060271028 | Altshuler et al. | Nov 2006 | A1 |
20060282067 | Koop et al. | Dec 2006 | A1 |
20060287646 | Altshuler et al. | Dec 2006 | A1 |
20060293727 | Spooner et al. | Dec 2006 | A1 |
20060293728 | Roersma et al. | Dec 2006 | A1 |
20070027440 | Altshuler et al. | Feb 2007 | A1 |
20070038271 | Cole et al. | Feb 2007 | A1 |
20070038206 | Altshuler et al. | Mar 2007 | A1 |
20070049910 | Altshuler et al. | Mar 2007 | A1 |
20070060819 | Altshuler et al. | Mar 2007 | A1 |
20070060989 | Deem et al. | Mar 2007 | A1 |
20070067006 | Altshuler et al. | Mar 2007 | A1 |
20070073308 | Anderson et al. | Mar 2007 | A1 |
20070078501 | Altshuler et al. | Apr 2007 | A1 |
20070088206 | Peyman | Apr 2007 | A1 |
20070093797 | Chan et al. | Apr 2007 | A1 |
20070105212 | Oldham et al. | May 2007 | A1 |
20070121069 | Andersen et al. | May 2007 | A1 |
20070123851 | Alejandro et al. | May 2007 | A1 |
20070142881 | Hennings | Jun 2007 | A1 |
20070159592 | Rylander et al. | Jul 2007 | A1 |
20070173749 | Williams et al. | Jul 2007 | A1 |
20070179378 | Boese et al. | Aug 2007 | A1 |
20070179470 | Toombs | Aug 2007 | A1 |
20070185552 | Masotti et al. | Aug 2007 | A1 |
20070191827 | Lischinsky et al. | Aug 2007 | A1 |
20070194717 | Belikov et al. | Aug 2007 | A1 |
20070197883 | Zhou et al. | Aug 2007 | A1 |
20070198004 | Altshuler et al. | Aug 2007 | A1 |
20070208252 | Makower | Sep 2007 | A1 |
20070213696 | Altshuler et al. | Sep 2007 | A1 |
20070213698 | Altshuler et al. | Sep 2007 | A1 |
20070213792 | Yaroslavsky et al. | Sep 2007 | A1 |
20070213851 | Bellas et al. | Sep 2007 | A1 |
20070219602 | Ostrovsky et al. | Sep 2007 | A1 |
20070219604 | Yaroslavsky et al. | Sep 2007 | A1 |
20070219605 | Yaroslavsky et al. | Sep 2007 | A1 |
20070239142 | Altshuler et al. | Oct 2007 | A1 |
20070239143 | Altshuler et al. | Oct 2007 | A1 |
20070244527 | Hatayama et al. | Oct 2007 | A1 |
20070255355 | Altshuler et al. | Nov 2007 | A1 |
20070260230 | Youngquist et al. | Nov 2007 | A1 |
20070264625 | DeBenedictis | Nov 2007 | A1 |
20070288071 | Rogers et al. | Dec 2007 | A1 |
20080003536 | Altshuler et al. | Jan 2008 | A1 |
20080004608 | Dacquay et al. | Jan 2008 | A1 |
20080004611 | Houbolt et al. | Jan 2008 | A1 |
20080009842 | Manstein et al. | Jan 2008 | A1 |
20080031288 | Sierra et al. | Feb 2008 | A1 |
20080033516 | Altshuler et al. | Feb 2008 | A1 |
20080058782 | Frangcischelli | Mar 2008 | A1 |
20080058783 | Altshuler et al. | Mar 2008 | A1 |
20080082089 | Jones et al. | Apr 2008 | A1 |
20080103565 | Altshuler et al. | May 2008 | A1 |
20080132886 | Cohen et al. | Jun 2008 | A1 |
20080139901 | Altshuler et al. | Jun 2008 | A1 |
20080140164 | Oberreiter et al. | Jun 2008 | A1 |
20080147054 | Altshuler et al. | Jun 2008 | A1 |
20080154157 | Altshuler et al. | Jun 2008 | A1 |
20080154247 | Dallarosa | Jun 2008 | A1 |
20080172047 | Altshuler et al. | Jul 2008 | A1 |
20080183162 | Altshuler et al. | Jul 2008 | A1 |
20080183250 | Tanojo et al. | Jul 2008 | A1 |
20080186591 | Altshuler et al. | Aug 2008 | A1 |
20080194969 | Werahera et al. | Aug 2008 | A1 |
20080195183 | Botchkareva et al. | Aug 2008 | A1 |
20080208105 | Zelickson et al. | Aug 2008 | A1 |
20080214988 | Altshuler et al. | Sep 2008 | A1 |
20080215038 | Bakker | Sep 2008 | A1 |
20080248554 | Merchant et al. | Oct 2008 | A1 |
20080259969 | Piper et al. | Oct 2008 | A1 |
20080262577 | Altshuler et al. | Oct 2008 | A1 |
20080294150 | Altshuler et al. | Nov 2008 | A1 |
20080294152 | Altshuler et al. | Nov 2008 | A1 |
20080294153 | Altshuler et al. | Nov 2008 | A1 |
20080306471 | Altshuler et al. | Dec 2008 | A1 |
20080319430 | Zenzie et al. | Dec 2008 | A1 |
20090014843 | Kawashita et al. | Jan 2009 | A1 |
20090018531 | Welches | Jan 2009 | A1 |
20090018624 | Levinson et al. | Jan 2009 | A1 |
20090024023 | Welches et al. | Jan 2009 | A1 |
20090024192 | Knowlton | Jan 2009 | A1 |
20090024193 | Altshuler et al. | Jan 2009 | A1 |
20090043294 | Island et al. | Feb 2009 | A1 |
20090048557 | Yeshurun et al. | Feb 2009 | A1 |
20090069741 | Altshuler et al. | Mar 2009 | A1 |
20090132011 | Altshuler et al. | May 2009 | A1 |
20090137995 | Altshuler et al. | May 2009 | A1 |
20090149843 | Smits et al. | Jun 2009 | A1 |
20090149844 | Altshuler et al. | Jun 2009 | A1 |
20090222068 | Oberreiter et al. | Sep 2009 | A1 |
20090227995 | Bhawalkar et al. | Sep 2009 | A1 |
20090248004 | Altshuler et al. | Oct 2009 | A1 |
20090254076 | Altshuler et al. | Oct 2009 | A1 |
20090287195 | Altshuler et al. | Nov 2009 | A1 |
20090292277 | Sierra | Nov 2009 | A1 |
20090312749 | Pini et al. | Dec 2009 | A1 |
20100010507 | Kinoshita | Jan 2010 | A1 |
20100014543 | Ogilvy et al. | Jan 2010 | A1 |
20100015576 | Altshuler et al. | Jan 2010 | A1 |
20100021867 | Altshuler et al. | Jan 2010 | A1 |
20100036295 | Altshuler et al. | Feb 2010 | A1 |
20100049180 | Wells et al. | Feb 2010 | A1 |
20100109041 | Yin et al. | May 2010 | A1 |
20100123399 | Bollmann et al. | May 2010 | A1 |
20100145321 | Altshuler et al. | Jun 2010 | A1 |
20100195680 | Sierra et al. | Aug 2010 | A1 |
20100198134 | Eckhouse et al. | Aug 2010 | A1 |
20100204686 | Yaroslavksy et al. | Aug 2010 | A1 |
20100217248 | Mirkov et al. | Aug 2010 | A1 |
20100278756 | Chung et al. | Nov 2010 | A1 |
20100286673 | Altshuler et al. | Nov 2010 | A1 |
20100296531 | Hohm et al. | Nov 2010 | A1 |
20100298744 | Altshuler et al. | Nov 2010 | A1 |
20110046523 | Altshuler et al. | Feb 2011 | A1 |
20110087155 | Uhland et al. | Apr 2011 | A1 |
20110118722 | Lischinsky et al. | May 2011 | A1 |
20110137230 | Altshuler et al. | Jun 2011 | A1 |
20110152847 | Mirkov et al. | Jun 2011 | A1 |
20110172651 | Altshuler et al. | Jul 2011 | A1 |
20110182306 | Hosseini et al. | Jul 2011 | A1 |
20110184334 | Altshuler et al. | Jul 2011 | A1 |
20110207075 | Altshuler et al. | Aug 2011 | A1 |
20110257584 | Altshuler et al. | Oct 2011 | A1 |
20110267830 | Altshuler et al. | Nov 2011 | A1 |
20110306956 | Islam | Dec 2011 | A1 |
20110313408 | Tankovich et al. | Dec 2011 | A1 |
20120022510 | Welches et al. | Jan 2012 | A1 |
20120023129 | Vedula et al. | Jan 2012 | A1 |
20120083862 | Altshuler et al. | Apr 2012 | A1 |
20120099816 | Wilson | Apr 2012 | A1 |
20120116271 | Caruso et al. | May 2012 | A1 |
20120165725 | Chomas et al. | Jun 2012 | A1 |
20120277659 | Yaroslavsky et al. | Nov 2012 | A1 |
20120301842 | Altshuler et al. | Nov 2012 | A1 |
20150180193 | Sierra | Jun 2015 | A1 |
Number | Date | Country |
---|---|---|
400305 | Apr 1995 | AT |
1851583 | Mar 1984 | AU |
2053926 | Mar 1990 | CN |
1073607 | Jun 1993 | CN |
1182572 | May 1998 | CN |
1351483 | May 2002 | CN |
1535126 | Oct 2004 | CN |
2826383 | Dec 1979 | DE |
3304230 | Aug 1984 | DE |
8807746 | Jan 1988 | DE |
3837248 | May 1990 | DE |
3841503 | Jun 1990 | DE |
9102407 | Jul 1991 | DE |
3719561 | Jan 1998 | DE |
19803460 | Aug 1999 | DE |
19944401 | Mar 2001 | DE |
10112289 | Aug 2001 | DE |
10140715 | Mar 2002 | DE |
10120787 | Jan 2003 | DE |
0000593 | Feb 1979 | EP |
0142671 | May 1985 | EP |
0172490 | Feb 1986 | EP |
0297360 | Jan 1989 | EP |
0320080 | Jun 1989 | EP |
0324120 | Jul 1989 | EP |
0413025 | Feb 1991 | EP |
0458576 | Nov 1991 | EP |
0563953 | Oct 1993 | EP |
0565331 | Oct 1993 | EP |
0575274 | Dec 1993 | EP |
0593375 | Apr 1994 | EP |
0598984 | Jun 1994 | EP |
0709941 | May 1996 | EP |
0724894 | Aug 1996 | EP |
0726083 | Aug 1996 | EP |
0736308 | Oct 1996 | EP |
0743029 | Nov 1996 | EP |
0755698 | Jan 1997 | EP |
0763371 | Mar 1997 | EP |
0765673 | Apr 1997 | EP |
0765674 | Apr 1997 | EP |
0783904 | Jul 1997 | EP |
0884066 | Dec 1998 | EP |
0885629 | Dec 1998 | EP |
0920840 | Jun 1999 | EP |
0927544 | Jul 1999 | EP |
1031414 | Aug 2000 | EP |
1038505 | Sep 2000 | EP |
1057455 | Dec 2000 | EP |
1072402 | Jan 2001 | EP |
1075854 | Feb 2001 | EP |
1138269 | Apr 2001 | EP |
1138349 | Oct 2001 | EP |
1147785 | Oct 2001 | EP |
1219258 | Jul 2002 | EP |
1226787 | Jul 2002 | EP |
1238683 | Sep 2002 | EP |
1250893 | Oct 2002 | EP |
1057454 | Nov 2003 | EP |
1457234 | Sep 2004 | EP |
1495735 | Jan 2005 | EP |
1512373 | Mar 2005 | EP |
1535582 | Jun 2005 | EP |
1627662 | Feb 2006 | EP |
1650615 | Apr 2006 | EP |
1797836 | Jun 2007 | EP |
1839705 | Oct 2007 | EP |
1854505 | Nov 2007 | EP |
2199453 | Apr 1974 | FR |
2591902 | Jun 1987 | FR |
1251424 | Oct 1971 | GB |
1274017 | May 1972 | GB |
1546625 | May 1979 | GB |
2044908 | Oct 1980 | GB |
2059053 | Apr 1981 | GB |
2059054 | Apr 1981 | GB |
2123287 | Feb 1984 | GB |
2212010 | Jul 1989 | GB |
2239675 | Jul 1991 | GB |
2270159 | Mar 1994 | GB |
2356570 | May 2001 | GB |
2360461 | Sep 2001 | GB |
2360946 | Oct 2001 | GB |
2364376 | Jan 2002 | GB |
2368020 | Apr 2002 | GB |
2390021 | Dec 2003 | GB |
2397528 | Jul 2004 | GB |
S54129791 | Oct 1979 | JP |
S5552766 | Apr 1980 | JP |
S55577187 | Jun 1980 | JP |
S574007 | Jan 1982 | JP |
S62165985 | Jul 1987 | JP |
S6323648 | Jan 1988 | JP |
S63249577 | Oct 1988 | JP |
S6427554 | Jan 1989 | JP |
H0366387 | Mar 1989 | JP |
S6481222 | Mar 1989 | JP |
H01181877 | Jul 1989 | JP |
H02199 | Jan 1990 | JP |
H022199 | Jan 1990 | JP |
H0213014 | Jan 1990 | JP |
H0285694 | Mar 1990 | JP |
H02174804 | Jul 1990 | JP |
H02285694 | Nov 1990 | JP |
H0319385 | Jan 1991 | JP |
H0316956 | Feb 1991 | JP |
H03183184 | Aug 1991 | JP |
H03281390 | Dec 1991 | JP |
H0622871 | Feb 1994 | JP |
H06154239 | Jun 1994 | JP |
H079179 | Jan 1995 | JP |
H0763957 | Mar 1995 | JP |
H07328025 | Dec 1995 | JP |
H0815539 | Jan 1996 | JP |
H0854538 | Feb 1996 | JP |
H0984803 | Mar 1997 | JP |
H09141869 | Jun 1997 | JP |
H09220292 | Aug 1997 | JP |
H1014661 | Jan 1998 | JP |
H0199574 | Apr 1998 | JP |
H1147146 | Feb 1999 | JP |
H11232229 | May 1999 | JP |
2000037400 | Feb 2000 | JP |
2000153003 | Jun 2000 | JP |
2000300684 | Oct 2000 | JP |
2001000560 | Jan 2001 | JP |
2001029124 | Feb 2001 | JP |
2001145520 | May 2001 | JP |
2001196665 | Jul 2001 | JP |
2001343560 | Dec 2001 | JP |
2002272861 | Sep 2002 | JP |
2003052843 | Feb 2003 | JP |
2005017796 | Jan 2005 | JP |
2005027702 | Feb 2005 | JP |
2006192073 | Jul 2006 | JP |
2082337 | Jun 1997 | RU |
2089126 | Sep 1997 | RU |
2089127 | Sep 1997 | RU |
2096051 | Nov 1997 | RU |
2122848 | Dec 1998 | RU |
WO 1986002783 | May 1986 | WO |
WO 1996028212 | Sep 1986 | WO |
WO 1988004592 | Jun 1988 | WO |
WO 1990000420 | Jan 1990 | WO |
WO 1990006727 | Jun 1990 | WO |
WO 1990012548 | Nov 1990 | WO |
WO 1991001053 | Jan 1991 | WO |
WO 1991002562 | Mar 1991 | WO |
WO 1991012050 | Aug 1991 | WO |
WO 1991013652 | Sep 1991 | WO |
WO 1991013653 | Sep 1991 | WO |
WO 1991018646 | Dec 1991 | WO |
WO 1992016338 | Jan 1992 | WO |
WO 1992003977 | Mar 1992 | WO |
WO 1992006739 | Apr 1992 | WO |
WO 1992019165 | Nov 1992 | WO |
WO 1993005920 | Apr 1993 | WO |
WO 1993021843 | Nov 1993 | WO |
WO 1995032441 | Jan 1995 | WO |
WO 1995003089 | Feb 1995 | WO |
WO 1995004393 | Feb 1995 | WO |
WO 1995033518 | Feb 1995 | WO |
WO 1995010243 | Apr 1995 | WO |
WO 1995014251 | May 1995 | WO |
WO 1995015725 | Jun 1995 | WO |
WO 1996009853 | Apr 1996 | WO |
WO 1996018347 | Jun 1996 | WO |
WO 1996022741 | Aug 1996 | WO |
WO 1996022813 | Aug 1996 | WO |
WO 1996023447 | Aug 1996 | WO |
WO 1996024182 | Aug 1996 | WO |
WO 1996024406 | Aug 1996 | WO |
WO 1996025979 | Aug 1996 | WO |
WO 1996034316 | Oct 1996 | WO |
WO 1996036396 | Nov 1996 | WO |
WO 1996039734 | Dec 1996 | WO |
WO 1996041579 | Dec 1996 | WO |
WO 1997000777 | Jan 1997 | WO |
WO 1997013458 | Apr 1997 | WO |
WO 1997013552 | Apr 1997 | WO |
WO 1997022384 | Jun 1997 | WO |
WO 1997028752 | Aug 1997 | WO |
WO 1997037602 | Oct 1997 | WO |
WO 1997037723 | Oct 1997 | WO |
WO 1998004317 | Feb 1998 | WO |
WO 1998005286 | Feb 1998 | WO |
WO 1998005380 | Feb 1998 | WO |
WO 1998006456 | Feb 1998 | WO |
WO 1998007379 | Feb 1998 | WO |
WO 1998020937 | May 1998 | WO |
WO 1998024507 | Jun 1998 | WO |
WO 1998029134 | Jul 1998 | WO |
WO 1998041158 | Sep 1998 | WO |
WO 1998051235 | Nov 1998 | WO |
WO 1998052481 | Nov 1998 | WO |
WO 1998058595 | Dec 1998 | WO |
WO 1999010046 | Mar 1999 | WO |
WO 1999017666 | Apr 1999 | WO |
WO 1999017667 | Apr 1999 | WO |
WO 1999017668 | Apr 1999 | WO |
WO 1999027997 | Jun 1999 | WO |
WO 1999029243 | Jun 1999 | WO |
WO 1999034867 | Jul 1999 | WO |
WO 1999043387 | Jul 1999 | WO |
WO 1999038569 | Aug 1999 | WO |
WO 1999039410 | Aug 1999 | WO |
WO 1999044638 | Sep 1999 | WO |
WO 1999046005 | Sep 1999 | WO |
WO 1999049937 | Oct 1999 | WO |
WO 1999058195 | Nov 1999 | WO |
WO 1999062472 | Dec 1999 | WO |
WO 1999066988 | Dec 1999 | WO |
WO 2000002491 | Jan 2000 | WO |
WO 2000003257 | Jan 2000 | WO |
WO 2000007514 | Feb 2000 | WO |
WO 2000030714 | Jun 2000 | WO |
WO 2000032272 | Jun 2000 | WO |
WO 2000040266 | Jul 2000 | WO |
WO 2000041278 | Jul 2000 | WO |
WO 2000043070 | Jul 2000 | WO |
WO 2000044294 | Aug 2000 | WO |
WO 2000053113 | Sep 2000 | WO |
WO 2000054649 | Sep 2000 | WO |
WO 2000054685 | Sep 2000 | WO |
WO 2000062700 | Oct 2000 | WO |
WO 2000064537 | Nov 2000 | WO |
WO 2000066226 | Nov 2000 | WO |
WO 2000071045 | Nov 2000 | WO |
WO 2000074583 | Dec 2000 | WO |
WO 2000074781 | Dec 2000 | WO |
WO 2000078242 | Dec 2000 | WO |
WO 2001014012 | Mar 2001 | WO |
WO 2001026573 | Apr 2001 | WO |
WO 2001034048 | May 2001 | WO |
WO 2001042671 | Jun 2001 | WO |
WO 2001003257 | Jul 2001 | WO |
WO 0161801 | Aug 2001 | WO |
WO 2001054606 | Aug 2001 | WO |
WO 2001054770 | Aug 2001 | WO |
WO 2001078830 | Oct 2001 | WO |
WO 2002009813 | Feb 2002 | WO |
WO 2002026147 | Apr 2002 | WO |
WO 2002053050 | Jul 2002 | WO |
WO 2002069825 | Sep 2002 | WO |
WO 2002078559 | Oct 2002 | WO |
WO 2002094116 | Nov 2002 | WO |
WO 2003005883 | Jan 2003 | WO |
WO 2003049633 | Jun 2003 | WO |
WO 2003103529 | Dec 2003 | WO |
WO 2004000150 | Dec 2003 | WO |
WO 2004011848 | Feb 2004 | WO |
WO 2004033040 | Apr 2004 | WO |
WO 2004037068 | May 2004 | WO |
WO 2004037287 | May 2004 | WO |
WO 2006089227 | Aug 2004 | WO |
WO 2004073537 | Sep 2004 | WO |
WO 2004080279 | Sep 2004 | WO |
WO 2004084752 | Oct 2004 | WO |
WO 2004086947 | Oct 2004 | WO |
WO 2005007003 | Jan 2005 | WO |
WO 2005009266 | Feb 2005 | WO |
WO 2005030317 | Apr 2005 | WO |
WO 2005046793 | May 2005 | WO |
WO 2005065288 | Jul 2005 | WO |
WO 2005092438 | Oct 2005 | WO |
WO 2005096981 | Oct 2005 | WO |
WO 2005099369 | Oct 2005 | WO |
WO 2005112815 | Dec 2005 | WO |
WO 2006006123 | Jan 2006 | WO |
WO 2006036968 | Apr 2006 | WO |
WO 2006066226 | Jun 2006 | WO |
WO 2006101735 | Sep 2006 | WO |
WO 2006116141 | Nov 2006 | WO |
WO 2007035444 | Mar 2007 | WO |
WO 2007122611 | Nov 2007 | WO |
WO 2008007218 | Jan 2008 | WO |
WO 2008070747 | Jun 2008 | WO |
WO 2008153999 | Dec 2008 | WO |
WO 2010102255 | Sep 2010 | WO |
WO 2012023129 | Feb 2012 | WO |
Entry |
---|
US 6,230,044 B1, 05/2001, Afanassieva et al. (withdrawn) |
[No Author] Bioptron Light Therapy System. Website print-out, accessed Jul. 13, 2006 (2 pages). |
[No Author] Derma Chiller advertisement (2 pages) from Paradigm Trex. |
[No Author] IPG Data Sheet for TFL Thulium Laser, Jun. 2001. |
[No Author] Webpage www.gallery.com—Rutile (Titanium Oxide)—Retrieved Oct. 3, 2011 from Http://www.galleries.com/minerals/oxides/rutile/rutile.htm. 2 pages. |
[No Author] Altea Therapeutics—Medicines Made Better (single page website print-out, retrieved Sep. 30, 2004, © 2003-2004). |
[No Author] Energy Systems Coropration, “A Practical Guide for the PhotoDern.RTM.VL user,” Haifa, Israel, Commercial Brochure 8 Pages, Oct. 1995. |
[No Author] “Final Report on the LFDL-10 Laser System for the GCA Corporation,” Candela Corp., Natick, MA, Section II, subsection 5, pp. 13-15 & 27, Mar. 1982. |
[No Author] “Fractional Photothermolysis Redefines Facial Skin Regeneration Science,” Aesthetic Buyers Guide, Mar./Apr. 2004, www.miinews.com, pp. 1-4. |
[No Author] “Hydrogel Dressings Contain Particles During Laser Therapy,” Dermatology Times, ISSN-01966197, p. 26 (1994). |
[No Author] “Instruction Manual, TFDL-10,” Adapted for SLAC, Candela Corporation, Natick, Oct. 1985. |
[No Author] “Lasers Battle for Prostatectomy Market,” Medical Laser Industry Report, 5:1-3 (Aug. 1991). |
[No Author] “LFDL-8 Instruction Manual,” Candela Laser Corporation, Wayland, MA Revised Oct. 1987. |
[No Author] “LFDL-8 Instruction Manual,” Candela Laser Corporation, Wayland, MA, Jan. 1982, Revised Jun. 1987. |
[No Author] “LFDL-8 Instruction Manual,” Cynosure, Inc., Bedford, MA, Revised Nov. 1992. |
[No Author] “Prostate Enlargement: Benigh Prostatic Hyperplasia,” brochure from U.S. Department of Health and Human Services, pp. 1-14, (at least by 1992). |
[No Author] “Special Instruction and Test Results for the LFDL-2 Wave Guide Laser,” Candela Laser Corporation, Wayland, MA, Sep. 1982. |
[No Author] “The Laser TURP Advantage,” Intra-Sonix, Inc. pp. 1-4 (1991). |
[No Author] Beckman Laser Institute “Experimental PDT to Prevent Esophegus Cancer,” (8 pages) 1996. |
[No Author] Cynosure Dioderm 510(k) Notification K992765 for Cynosure, Inc. to Food and Drug Administration, dated: Aug. 16, 1999 and Aug. 20, 1999 (Additional Information). |
[No Author] Reliant Technologies, Inc. “Physicians Guide: Understanding Faxel Laser Treatment,” pp. 1-10 (2004). |
[No Author] Ritter Sybron Corporation, “Electrosurgery, A Guide for Operating Room Personnel,” pp. 1-22, (Jun. 1976). |
[No Author] Selective Photothermolysis of Sebaceous Glands, Department of Health and Human Services, Public Health Service, Small Business Innovation Research Program II Grant Application, Cynosure, Inc., dated: Jul. 27, 2000, pp. 17-39 and 43-44. |
[No Author] “Innovative Non-Surgical Treatment for Barrett's Esophagus”, Jul. 1995, see http:/www.plsgroup.com/dg950728.htm. |
“American Society for Laser Medicine and Surgery Abstracts,” Lasers in Surgery and Medicine, Supplement 6, p. 46 (1994). |
Anderson, R.R., et al., “Microvasculature Can Be Selectively Damaged Using Dye Lasers: A Basic Theory and Experimental Evidence in Human Skin,” Lasers in Surgery and Medicine 1:263-276 (1981). |
Altshuler et al., “Human Tooth as an Optical Device,” SPIE vol. 1429 Holography and Interferometry and Optical Pattern Recognition in Biomedicine, pp. 95-104, 1991. |
Altshuler et al., “Modern Optics and Dentistry,” Laser in Dentistry, pp. 283-297, 1995. |
Altshuler et al., “New Optical Effects in the Human Hard Tooth Tissues,” Lasers and Medicine, Proc. SPIE vol. 1353, pp. 97-102, 1989. |
Altshuler, et al., “Self Canalization of Laser Microbeam in Tissue as Fundamental Mechanism of Fractional Skin Resurfacing”, Lasers in Surgery and Medicine Supple 15, 21, 2003. |
Altshuler, G.B. et al., “Acoustic response of hard dental tissues to pulsed laser action,” SPIE, vol. 2080, Dental Application of Lasers, pp. 97-103, 1993. |
Altshuler, G.B. et al., “Extended theory of selective photothermolysis,” Lasers in Surgery and Medicine, vol. 29, pp. 416-432, 2001. |
Amy, R.L. et al., “Selective mitochondrial damage by a ruby laser microbeam: An electron microscopic study,” Science, vol. 15, pp. 756-758, Nov. 1965. |
Anderson, R.R. et al., “Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation,” Science, vol. 220, pp. 524-527, Apr. 1983. |
Anderson, R.R. et al., “The optics of human skin,” Journal of Investigative Dermatology, vol. 77, No. 1, pp. 13-19, 1981. |
Ang et al., “Kalman Filtering for Real-Time Orientation Tracking of Handheld . . . ”, 2004 IEEE/RSJ Iner Conf on Intell Robots and Systems (IROS), Sendai, Japan. |
Ang et al., “Design of All-Accelerometer Inertial Measurement Unit for Tremor Sensing in Hand-Held . . . ”, 2003 IEEE Inter Conf on Robotice and Automation (col. 2), Taipei, Taiwan. |
Angelis, et al., “Fractional, Non-Ablative Laser Therapy for the Treatment of Striae Distensae”, White Paper published by Palomar Medical Technologies, Inc. (2009)5 pages. |
Apfelberg et al. “Analysis of Complications of Argon Laser Treatment for Port Wine Hemangiomas with Reference to Striped Technique,” Lasers in Surgery and Medicine, 2:357-371 (1983). |
Apfelberg et al. “Dot or Pointillistic Method for Improvement in Results of Hypertrophic Scarring in the Argon Laser Treatment of Portwine Hemangiomas,” Lasers in Surgery and Medicine, 6:552-558 (1987). |
Apfelberg, D.B., “A Preliminary Study of the Combined Effect of Neodymium:YAG Laser Photocoagulation and Direct Steroid Instillation in the Treatment of Capillary/Cavemous Hemangiomas of Infancy,” Department of Plastic Surgery and Comprehensive Laser Center, Palo Alto Medical Foundation, Palo Alto, CA, pp. 94-103 (1989). |
Apfelberg, D.B., “Combination Treatment for Massive Cavernous Hemangioma of the Face: YAG Laser Photocoagulation Pulse Direct Steroid Injection Followed by YAG Laser Resection with Sapphire Scalpel Tips, Aided by Superselective Embolization,” Lasers in Surgery and Medicine, 10:217-223 (1990). |
Belikov, A.V. et al., “Identification of enamel and dentine under tooth laser treatment,” SPIE vol. 2623, Progress in Biomedical Optics Europt Series, Proceedings of Medical Applications of Lasers III, pp. 109-116, Sep. 1995. |
Benjavitvilai, C. et al., “Fuzzy Calibration of Magnetometer in Presence of Surgical Microscope,” 2005 27th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (IEEE Cat. No. 05CH37811C), Shanghai, China, Aug. 31-Sep. 3, 2005. |
Bjerring, P. et al., “Selective Non-Ablative Wrinkle Reduction by Laser,” J Cutan Laser Ther, vol. 2, pp. 9-15, 2000. |
Blankenau et al., “In Vivo Caries-Like Lesion Prevention with Argon Laser: Pilot Study,” Journal of Clinical Laser Medicine and Surgery, vol. 17, No. 6, pp. 241-243, 1999. |
Bogdan Allemann, et al., “Laser Principles”, Physical and Electronic Properties of Lasers, Basics in Dermatological Laser Applications, Curr. Probl. Dermatol, Basel, Karger. Zurich, Switzerland and Miami, Florida. vol. 42, pp. 7-23, 2011, 17 pages. |
Bohm et al., “The Pilosebaceous Unit is Part of the Skin Immune System,” Dermatology, 196:75-79, 1998. |
Boiteux, M., et al., “A Transverse Flow Repetitive Dye Laser,” Applied Optics, 9, 514 (1970). |
Boulnois, J., “Photophysical Processes in Recent Medical Laser Developments: a Review,” Lasers in Medical Science, vol. 1:47-66 (1986). |
Brauer, Jeremy A. et al., “Successful and Rapid Treatment of Blue and Green Tattoo Pigment With a Novel Picosecond Laser”, Archives of Dermatology, vol. 148, No. 7, 2012, pp. 820-823. |
Britt et al., “The Effect of pH or Photobleaching of Organic Laser Dyes”, IEEE J. Quantum Electron. (Dec. 1972), 913-914. |
Burlamacchi et al, “A Simple Reliable Waveguide Dye Laser for Ophthalmological Applications,” Rev of Sci Instrum; vol. 46; No. 3; pp. 281-283, Mar. 1975. |
Chan, E.K., “Effects of Compression on Soft Tissue Optical Properties,” IEEE Journal of Selected Topics in Quantum Electronics, vol. 2, No. 4, pp. 943-950 (Dec. 1996). |
Costello, A. et al., “Nd:YAG Laser Ablation of the Prostate as a Treatment for Benign Prostatic Hypertrophy,” Lasers in Surgery and Medicine, 12:121-124 (1992). |
Cunliffe, “Acne Vulgaris. The Past, the Present and the Future,” Acta Bermatovener (Stockh) Suppl. 120, pp. 34-38, 1985. |
Dabrowska, “Intravital Treatment of the Pulp with Stimulation Laser Biostimulation,” Abstract Rocz-Akad-Med-Bialymst. 1997; 42(1): 168-76. |
Dierickx, C.C. et al., “Thermal Relaxation of Port-wine Stain Vessels Probed In Vivo: The Need for 1-10 Millisecond Laser Pulse Treatment,” The Journal for Investigative Dermatology, pp. 709-714 (1995). |
Dixon et al. “Hypertrophic Scarring in Argon Laser Treatment of Port-Wine Stains,” Plastic and Reconstructive Surgery, 73:771-777 (1984). |
Dock et al., “Clinical Histologic and Ultrastructural Evaluation of Solar Elastosis Treated With the Pulsed Dye Laser,” American Society for Laser Medicine and Surgery Abstracts, p. 54 (Apr. 1997). |
Doukas et al., “Transdermal Drug Delivery With a Pressure Wave,” Advanced Drug Delivery Reviews 56 (2004), pp. 559-579. |
Dover J.S. et al., “Pigmented guinea pig skin irradiated with Q-switched ruby laser pulses,” Arch Dermatol, vol. 125, pp. 43-49, Jan. 1989. |
Dufresne et al., “Squamous cell carcinoma arising from the follicular occlusion triad,” J. Am. Acad. Dermatol. 35(3), Part 1:475-477, 1996. |
Ellenberger, et al. “Single-Frequency Nd:Glass Laser Oscillator with Pulse-Transmission-Mode Q-Switch with Pulse-Transmission-Mode Q-Switch,” Optics communication, vol. 81, No. 6 (Mar. 1991). |
Ertan et al., “Esophagel Adenocarcinoma Associated with Barrett's Esophagus: Long-term Management with Laser Ablation”, Am. J. Gastro, 90: pp. 2201-2203, 1995. |
Fallon Friedlander, “Effective Treatment of Acne Fulminans-Associated Granulation Tissue with the Pulsed Dye Laser,” Pediatric Dermatology, 15(5):396-398, 1998. |
Finkelstein L.H. et al., “Epilation of hair-bearing urethral grafts using the neodymium:yag surgical laser,” Journal of Urology, vol. 146, pp. 840-842, Sep. 1991. |
Fiskerstrand E.J. et al., “Hair Removal with Long Pulsed Diode Lasers: A Comparison Between Two Systems with Different Pulse Structures,” Lasers in Surgery and Medicine, vol. 32, pp. 399-404, 2003. |
Fletcher, A.N. et al., “Improving the Output and Lifetime of Flashlamp-Pumped Dye Lasers” Proceedings of the International Conference on Lasers '85, pp. 797-804, Dec. 2-6, 1985. |
Forrest-Winchester et al., “The Effect of Infrared Laser Radiation on Dentinal Permeability in vitro,” Department of Dentistry, University of Queensland Dental School, pp. 1-8, 1992. |
Friedman-Birnbaum et al., “Seborrheic Skin and Acne Vulgaris as Protective Factors against the Development of Basal Cell Epithelioma,” Dermatolgica, 183:160-163, 1991. |
Furumoto, H., “Dye Chemistry and System Study for Optimum Laser Operation at 436 NM Using the LFDL-10 Laser,” Prepared for Burlington Division Geophysical Corporation of America, pp. 1-23, Mar. 1982. |
Ginsbach et al. “New Aspects in the Management of Benign Cutameous Tumors.” Laser 79 Opto-Electronics, Munich Conference Proceedings, 344-347 (1979). |
Goldberg, “Lasers for Facial Rejuvenation”, Am J. Clin, Dermatol., 4(4):225-234, 2003, 10 pages. |
Goldberg, “Nonablative Resurfacing”, Clinics in Plastic Surgery, Skin Laser and Surgery Specialists of New York and New Jersey. Westwood, New Jersey. vol. 27, No. 2, Apr. 2000, 6 pages. |
Goldman, L. et al. “Treatment of basal cell epithelioma by laser radiation,” JAMA, vol. 189, No. 10. pp. 773-775, 1964. |
Goldman, L. et al., “Effect of the laser beam on the skin, III. Exposure of cytological preparations,” Journal of Investigative Dermatology, vol. 42, pp. 247-251, 1964. |
Goldman, L. et al., “Effect of the laser beam on the skin, Preliminary report” Journal of Investigative Dermatology, vol. 40, pp. 121-122, 1963. |
Goldman, L. et al., “Impact of the laser on nevi and melanomas,” Archives of Dermatology, vol. 90, pp. 71-75, Jul. 1964. |
Goldman, L. et al., “Laser action at the cellular level,” JAMA, vol. 198, No. 6, pp. 641-644, Nov. 1966. |
Goldman, L. et al., “Laser treatment of tattoos, A preliminary survey of three year's clinical experience,” JAMA, vol. 201, No. 11, pp. 841-844, Sep. 1967. |
Goldman, L. et al., “Long-term laser exposure of a senile freckle,” ArchEnviron Health, vol. 22, pp. 401-403, Mar. 1971. |
Goldman, L. et al., “Pathology, Pathology of the effect of the laser beam on the skin,” Nature, vol. 197, No. 4870, pp. 912-914, Mar. 1963. |
Goldman, L. et al., “Preliminary Investigation of fat embolization from pulsed ruby laser impacts of bone,” Nature, vol. 221, pp. 361-363, Jan. 1969. |
Goldman, L. et al., “Radiation from a Q-switched ruby laser, EffeCt of repeated impacts of power output of 10 megawatts on a tattoo of man,” Journal of Investigative Dermatology, vol. 44, pp. 69-71, 1965. |
Goldman, L. et al., “Replica microscopy and scanning electron microscopy of laser impacts on the skin,” Journal of Investigative Dermatology, vol. 52, No. 1, pp. 18-24, 1969. |
Goldman, L. et al., “The biomedical aspects of lasers,” JAMA, vol. 188, No. 3, pp. 302-306, Apr. 1964. |
Goldman, L. et al., “The effect of repeated exposures to laser beams,” Acta derm.-vernereol., vol. 44, pp. 264-268, 1964. |
Goldman, L., “Dermatologic manifestations of laser radiation,” Proceedings of the First Annual Conference on Biologic Effects of Laser Radiation, Federation of American Societies for Experimental Biology, Supp. No. 14, pp. S-92-S-93, Jan.-Feb. 1965. |
Goldman, L., “Effects of new laser systems on the skin,” Arch Dermatol., vol. 108, pp. 385-390, Sep. 1973. |
Goldman, L., “Laser surgery for skin cancer,” New York State Journal of Medicine, pp. 1897-1900, Oct. 1977. |
Goldman, L., “Surgery by laser for malignant melanoma,” J. Dermatol. Surg. Oncol., vol. 5, No. 2, pp. 141-144, Feb. 1979. |
Goldman, L., “The skin.” Arch Environ Health, vol. 18, pp. 434-436, Mar. 1969. |
Goldman, L., Biomedical Aspects of the Laser, Springer-Verlag New York Inc., publishers, Chapts. 1, 2 & 23, 1967. |
Goldman, M. P., “Leg Veins and Lasers,” American Society for Laser Medicine and Surgery Abstracts, Fourteen Annual Meeting, Toronto, Ontario, Canada, p. 48 (Apr. 8-10, 1994). |
Goldman, M.P., “Sclerotherapy—Treatment of Varicose and Telangiectatic Leg Veins,” Second Edition, Mosby, pp. 454-467 (1995). |
Gottlieb, I., “Power Supplies, Switching Regulators, Inverters & Converters,” 1976. |
Greenwald et al. “Comparative Histological Studies of the Tunable Dye (at 577 nm) Laser and Argon Laser: The Specific Vascular Effects of the Dye Laser,” The Journal of Investigative Dermatology, 77:305-310 (1981). |
Grossman, et al., “780 nm Low Power Diode Laser Irradiation Stimulates Proliferation of Keratinocyte Cultures: Involvement of Reactive Oxygen Species,” Lasers in Surgery and Medicine vol. 29, pp. 212-218, 1998. |
Grossman, M.C. et al., “Damage to hair follicles by normal-mode ruby laser pulses,” Journal of he American Academy of Dermatology, vol. 35, No. 6, pp. 889-894, Dec. 1996. |
Grossman, M.C. et al., “Laser Targeted at Hair Follicles,” Lasers Med Surg., Suppl. 13:221 (2001). |
Habbema, Louis et al., “Minimally invasive non-thermal laser technology using laser-induced optical breakdown fir skin rejuvenation”, J. Biophotonics, vol. 5, No. 2, 2012, pp. 194-199. |
Haedersal, et el., “Fractional Nonablative 1540 nm Laser Resurfacing for Thermal Bum Scars: A Randomized Controlled Trial”, Lasers in Surgery and Medicine, 41:189-195, 2009, 7 pages. |
Hicks et al., “After Low Fluence Argon Laser and Flouride Treatment,” Compendium, vol. 18, No. 6, Jun. 1997. |
Hicks et al., “Enamel Carries Initiation and Progression Following Low Fluence (energy) and Argon Laser and Fluoride Treatment,” The Journal of Clinical Pediatric Dentistry, vol. 20, No. 1 pp. 9-13, 1995. |
Hsu et al., “Combined Effects of Laser Irradiation/Solution Flouride Ion on Enamel Demineralization,” Journal of Clinical Laser Medicine and Surgery, vol. 16, No. 2 pp. 93-105, 1998. |
Hulsbergen Henning et al. “Clinical and Histological Evaluation of Portwine Stain Treatment with a Microsecond-Pulsed Dye-Laser at 577 NM,” Lasers in Surgery and Medicine, 4:375-380 (1984). |
Hulsbergen Henning et al., “Port Wine Stain Coagulation Experiments with a 540-nm Continuous Wave Dye-Laser,” Lasers in Surgery and Medicine, 2:205-210 (1983). |
Invention description to certificate of authorship, No. 719439, “The ring resonator of optical quantum generator” (Aug. 15, 1975). |
Invention description to certificate of authorship, No. 741747, “The modulator of optical radiation intensity” (Oct. 10, 1977). |
Invention description to certificate of authorship, No. SU 1257475 A1, “Laser interferometric device to determine no-linearity of an index of refraction of optical medium” (Sep. 15, 1986). |
Invention description to certificate of authorship, No. SU 1326962 A1, “The way of determination of non-linearity of an index of refraction of optical medium” (Jul. 30, 1987). |
Invention description to certificate of autorship, No. 532304, “The way of investigation of radiation time structure of optical quantum generator” (Jul. 9, 1974). |
Ivanov, A.P. et al., “Radiation Propagation in Tissues and Liquids with Close Particle Packing,” Zhurnal Prikladnoi Spektroskopii, vol. 47, No. 4, pp. 682-668 (Oct. 1987). |
Johnsson et al., “No photoinactivation of Propionibacterium acnes with soft laser treatment,” Dermatologica, 175(1):50, 1987. |
Kalivradzhiyan et al., “The Usage of Low Intensity Laser Radiation for the Treatment of the Inflammatory processes of the Oral Cavity Mucosa after Applying Removable Plate Dentures,” SPIE vol. 1984 pp. 225-230. |
Kandel, Laurence B., M.D., et al., “Transurethral Laser Prostatectomy in the Canine Model,” Lasers in Surgery and Medicine, 12:33-42 (1992). |
Kantor et al., “Treatment of acne keloidalis nuchae with carbon dioxide laser,” J. Am. Acad. Dermatol., 14:263-267, 1986. |
Karu, “Cell Attachment to Extracellular Matrics is Modulated by Pulsed Radiation at 820 nm and Chemicals that Modify the Activity of Enzymes in the Plasma Membrane,” Laser in Surgery and Medicine, vol. 29, pp. 274-281, 2001. |
Karu, “Photobiological Fundamentals of Low-Power Laser Therapy,” 8th Congress of International Society for Laser Surgery and Medicine, Mar. 30, 1987. |
Kazmina et al., “Laser Prophiaxis and Treatment of Primary caries,” SPIE vol. 1984, pp. 231-233. |
Kelly et al., “Nonablative Laser Treatment of Facial Rhytides: United States Phase II Clinical Study,” American Society for Laser Medicine and Surgery Abstracts, 10(33):38 (1998). |
Kilmer et al., “Pulse Dye Laser Treatment of Rhytids,” American Society for Laser Medicine and Surgery Abstracts, p. 44 (Apr. 1997). |
Klein, E. et al., “Biological effects of laser radiation 1.,”Northeast Electroncis Research and Engineering Meeting, NEREM Record, IEEE catalogue No. F-60, pp. 108-109, 1965. |
Kliewer, Michael L. et al., “Excited State Absorption of Pump Radiation as a Loss Mechanism in Solid-State Lasers”, IEEE Journal of Quantum Electronics, vol. 25, 1989, pp. 1850-1854. |
Korobov et al., “Dependence of the Quantum Yield of Intercombinational Conversion into the Triplet State of Rhodamine 6G on the pH of the Medium”, Zhur. Prikl. Spektrosk. 24(1) 28-31 (Jan. 1976). |
Kozlov et al., “Laser in Diagnostics and Treatment of Microcirculation Disorders Under Parodontitis,” SPIE vol. 1984, pp. 253-264. |
Krames et al. “Status and Future of High-Power Light-Emitting Diodes for Solid State Lighting”, J. Display Technol., 3(2):160-175 (Jun. 2007). |
Kuhns, J.G. et al., “Biological effects of laser radiation II Effects of laser irradiation on the skin,” NEREM Record, pp. 152-153, 1965. |
Kuhns J.G. et al., “Laser injury in skin,” Laboratory Investigation, vol. 17, No. 1, pp. 1-13, Jul. 1967. |
Kuizenga, Dirk J. et al., “FM and AM Mode Locing of the Homogenous Laser-Part I: Theory”, IEEE Journal of Quantum Electronics, vo. 6, No. 11, Nov. 1970, pp. 694-708. |
Lee, Junsu et al., “Q-switched Mode-Locking of an Erbium-doped Fiber Laser through Subharmonic Cavity Modulation”, Photonics Conference (IPC), 202 IEEE, Sep. 23, 2012, pp. 664-665. |
Leger, J. et al., “Geometrical Transformation of Linear Diode-Laser Arrays for Longitudinal Pumping of Solid-State Lasers”, IEEE Journal of Quantum Electronics, vol. 28, No. 4, Apr. 1992. |
Lesnik et al., “Agents that cause enlargement of sebaceous glands in hairless mice,” Arch. Dermatol., 284:100-105, 1992. |
Levin, G. et al., “Designing with hyseretic current-mode control,” EDN Magazine, pp. 1-8, Apr. 11, 1996. |
Levin, G. et al., “Designing with hyseretic current-mode control,” EDN Magazine, pp. 1-8, Apr. 28, 1994. |
Lucchina et al., “Fluorescence photography in the evaluation of acne,” J. Am. Acad. Dermatol. 35:58-63 (1996). |
Maegawa, et al., “Effects of Near-Infrared Low-Level Laser Irradiation on Microcirculation,” Lasers in Surgery and Medicine, vol. 27, pp. 427-437, 2000. |
Mamedova et al., “Microbiological Estimate of Parodontis Laser Therapy Efficiency,” SPIE vol. 1984, pp. 247-249. |
Mang, “Effect of Soft Laser Treatment on Wound Healing in the Hamster Oral Mucosa,” Lasers in Surgery and Medicine, Supp. 8, Abstracts, Abstract 25, 1996. |
Manstein, D. et al., “Selective Photothermolysis of Lipid-Rich Tissue,” American Society for Laser medicine and Surgery Abstracts, No. 17, American Society for Laser Medicine and Surgery Twenty-First Annual Meeting, Apr. 20-22, 2001, p. 6. |
Manstein, D., et al., “Fractional Photothermolysis: A New Concept for Cutaneous Remodeling Using Microscopic Patterns of Thermal Injury,” Lasers in Surgery and Medicine, 34: 426-438 (2004). |
Manuskiatti et al., “Laser hair removal affects sebaceous glands and sebum excretion . . . ,” J. Am. Acad. Dermatol., 41:176-180, 1999. |
Margolis, R.J. et al., “Visible action spectrum for melanin-specific selective photothermolysis,” Lasers in Surgery and Medicine, vol. 9, pp. 389-397, 1989. |
Marinelli et al., “Diode laser illuminated automotive lamp systems,” SPIE Proceedings vol. 3285:170-177 (1998). |
Marshak, I.S., et al., “Pulsed Light Sources,” State Power Engineering Press, Moscow and Leningrad (1963). |
Matsunaga et al., “Effect of pH on Dye-Laser Output Power”, J. Appl. Phys. 48(2):842-844 (Feb. 1977). |
McCullough, David L., M.D., “Transurethral Laser Treatment of Benign Prostatic Hyperplasia,” and “Transurethral Ultrasound-guided Laser-Induced Prostatectomy (TULIP) Procedure): A Canine Prostate Feasibility Study,” by Roth, Robert A., M.D., et al., The Journal of Urology, 146:1126-1135 (1991). |
McDaniel, et al., “Hexascan: A New Robotized Scanning Laser Handpiece,” Cutis, 45:300-305 (1990). |
McNicholas, T. A., et al., “Interstitial Laser Coagulation of the Prostate: Experimental Studies,” SPIE, 1421:30-35 (1991). (From Proceedings of Lasers in Urol., Laparoscopy, and General Surgery, Jan. 21-23, 1991). |
Mingxin, Qiu et al., “Performance of a Nd:YVO4 microchip laser with continuous-wave pumping at wavelengths between 741 and 825 nm”, Applied Optics, vol. 32, No. 12, Apr. 20, 1993, p. 2085. |
Moretti, Michael, “Holmium Boosts Orthopedic Laser Development,” Medical Laser Buyers Guide, p. 93 (1992). |
Moretti, Michael, “Lasers Improve Prostatectomy Treatment,” Medical Laser Buyers Guide. p. 94-96 (1992). |
Mostovnikov, V.A. et al., “Recovery of Lasing Properties of Dye Solutions after Their Photolysis,” Sov. J. Quantum Electron, 6(9), Sep. 1976, pp. 1126-1128. |
Nanni, C.A. et al., “Complications of Carbon Dioxide Laser Resurfacing,” Washington Inst. of Dermatol. Surg. 24:315-320 (1998). |
Nemeth, et al., “Copper vapor laser treatment of pigmented lesions,” Lasers Surg. Med. Supp. 2:51 (1990). |
Ogiso et al, “Phase Transitions of Rat Stratum Corneum Lipids by an Electron Paramagnetic Resonance Study and Relationship of Phase States to Drug Penetration,” Biochimica et Biophysica Acta 1301:97-104 (1996). |
Ohbayashi, “Stimulatory Effect of Laser Irradiation an Calcified Nodule Formation in Human Dental Pulp Fibroblasts,” Abstract J-Endod. Jan. 1999: 25(1): 30-3. |
Ohshiro et al., “The Ruby and Argon Lasers in the Treatment of the Naevi,” Annals Academy of Medicine, Apr. 1983, vol. 12, No. 2, pp. 388-395. |
Oleinik, et al., “Automatized Securing Definition for Laser Therapy Indications in Case of Non-complicated Caries,” SPIE, vol. 1984, pp. 238-244. |
Oraevsky, Alexander A. et al., “Plasma Mediated Ablation of Biological Tissues with Nanosecond-to-Femtosecond Laser Pulses: Relative Role of Lineear and Nonlinear Absorption”, IEEE Journal of Selected Topics in Quantum Electronics, vol. 2, No. 4, Dec. 1996, pp. 801-809. |
Orchardson, “Effect of Pulsed Nd:YAG Laser Radiation on Action Potential Conduction in Nerve Fibres Inside Teeth in vitro,” Abstract J-Dent. Jul.-Aug. 1998; 26(5-6): 421-6. |
Overholt BF et al. “Balloon photodynamic therapy of esophageal cancer: effect of increasing balloon size.” PubMed; Lasers Surg Med. 1996, 18(3):248-52. |
Ozawa et al., “Stimulatory Effects of Low-Power Laser Irradiation on Bone Formation in vitro,” SPIE vol. 1984, pp. 281-288. |
Panjehpour M et al. “Spectroscopic diagnosis of esophageal cancer: new classification model, improved measurement system.” PubMed; Gastrointest Endosc. Jun. 1995; 41 (6):577-81. |
Parrish, J.A., “Selective thermal effects with pulsed irradiation from lasers: From organ to organelle,” Journal of investigative Dermatology, vol. 80, No. 6 Supplement, pp. 75s-80s, 1983. |
Petrischev et al. “Clinical and Experimental Low-Intense Laser Therapy in Dentistry,” SPIE, vol. 1984, pp. 212-214. |
Petrischev et al., “Report on Low Intensity Laser Radiation Usage in Dentistry,” SPIE vol. 1984, pp. 202-211. |
Polanyi, Thomas & Tobias, Irwin, Lasers-A Series of Advances, Edited by A.K. Levine, vol. 2, Marcel Dekker, Inc, N.Y., 1968, pp. 400, 402-403 & 422. |
Polla, L. et al., “Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin,” Journal of Investigative Dermatology, vol. 89, No. 3, pp. 281-286, Sep. 1987. |
Powell, “Laser Dental Decay Prevention: does it have a future?” SPIE vol. 3192, 1997. |
Reed J.T. et al., “Treatment of Periorbital Wrinkles,” Washington Inst. of Dermatol. Surg. 23:643-648 (1997). |
Remillard et al., “Diode laser illuminated automotive brake lamp using a linear fanout diffractive optical element,” Proc. of the Diffractive Optics and Micro-Optics Conference, OSA Technical Digest Series vol. 10, 192-194 (1998). |
Remillard et al., “Diode Laser illuminators for Night-Vision Applications,” SPIE Proceedings vol. 4285:14-22 (2001). |
Riggle et al., “Laser Effects on Normal and Tumor Tissue,” Laser Applications in Medicine and Biology, vol. 1, M.L Wolbarsht, editor, Plenum Press, publishers, Ch. 3, pp. 35-65 (1971). |
Rohrer, “Evaluating the Safety and Efficacy of a Novel Light Based Hair Removal System,” Lasers. Surg. Med. Supp.13:97 (2001). |
Rosenfeld, H., et al., “Treatment of Cutaneous and Deep Vascular Lesions with the Nd:YAG Laser,” Lasers in Surgery and Medicine, 6:20-23 (1986). |
Rotteleur, et al., “Robotized scanning laser handpiece for the treatment of port wine stains and other angiodysplasias,” Lasers Surg. Med., 8:283-287 (1998). |
Rubach et al., “Histological and Clinical Evaluation of Facial Resurfacing Using a Carbon Dioxide Laser With the Computer Pattern Generator,” Arch Otolaryngol Head Neck Surg., 123:929-934 (1997). |
Russel et al. “Flash-Lamp-Excited Self-Injection-Seeded Q-Switch Ti:Al2O3 Laser Oscillator,” Applied Optics, vol. 35, No. 24 (Aug. 1996). |
Rylander, C.G. et al., “Mechanical Tissue Optical Clearing Devices: Enhancement of Light Penetration in Ex Vivo Porcine Skin and Adipose Tissue,” Lasers in Surgery and Medicine, vol. 40, pp. 688-694 (2008). |
Sandford et al., “Thermal Effects During Desensitisation of Teeth with Gallium-Aluminum-Arsenide Lasers,” University of Queensland Dental School, Periodontology 15: 25-30 (1994). |
Schade, W. et al., “Temperature tuned distributed feedback dye laser with high repetition rate”, Applied Optics, vol. 2 9, No. 27, Sep. 20, 1990, pp. 3950-3954. |
Schappert et al., “Temperture Tuning of an Organic Dye Laser” Applied Physics Letters 13(4):124-126 (Aug. 15, 1968). |
Schindl, “Does Low Intensity Laser Irradiation Really Cause Cell Damage?” Laser in Surgery and Medicine vol. 22, pp. 105, 2001. |
Sheehan-Dare, et al., “Lasers in Dermatology,” British Journal of Dermatology, 129:1-8 (1993). |
Shimbashi, T. et al., “Ruby laser treatment of pigmented skin lesions,” Aesth. Plast. Surg., vol. 19, pp. 225-229, 1995. |
Shimizu et al., “Prospect of Relieving Pain Due to Tooth Movement During Orthodontic Treatment Utilizing a GA-AI as Diode Laser,” SPIE vol. 1984, pp. 275-280. |
Shumilovitch et at., “Influence of Low Intensity Laser Radiation Upon the Microflora of Carious Cavities and Root Canal,” SPIE vol. 1984, pp. 215-220. |
Shuster, “Acne: The Ashes of a Burnt Out Controversy,” Acta Derm. Venereol. Suppl. (Stockh), 120:43-46, 1985. |
Sigurdsson et al., “Phototherapy of Acne Vulgaris with Visible Light,” Dermatology, 194:256-260, 1997. |
Sing, “Electroacupuncture and Laser Stimulation Treatment: Evaluation by Somatosensory Evoked Potential in Conscious Rabbits,” Abstract AM-J-Chin-Med. 1997; 25(3-4): 263-71. |
Suney et al., “Safety with Lasers and Other Optical Sources: A Comprehensive Handbook,” Plenum Press, pp. 477-480 (1980). |
Sokolova et al., “Low-Intense Laser Radiation in Complex Treatment of Inflammatory Diseases of Parodontium,” SPIE vol. 1984, pp. 234-237. |
Spears et al., “Fluorescence of Experimental Atheromatous Plaques with Hematoporphyrin Derivative,” J. Clin. Invest, 71:395-399 (1983). |
Spotswood, “Novel Use of Fractional Lasers for Scarring Improves Quality of Life for Injured Troops”, http://www.usmedicine.com/articles/novel-use-of-fractional-lasers-for-scarring-improves-quality-of-life-for-injured-troops-.html, (Aug. 2012) , U.S. Medicine ISSN: 0191-6246. 4 pages. |
Stratton, K. et al., “Biological Effects of Laser Radiation Ii: ESR Studies of Melanin Containing Tissues after Laser Irradiation,” Northeast Electronics Research and Engineering Meeting—NEREM Record, IEEE Catalogue No. F-60, pp. 150-151, Nov. 1965. |
Strauss et al., “Skin Lipids and Acne,” Annu. Rev. Med., 26: 27-31, 1975. |
Sumian, C.C. et al., “A Preliminary Clinical and Histopathological Study of Laser Skin Resurfacing Using a frequency-Doubled Nd:YAG Laser After Application of Chromofilm®,” Journal of Cutaneous Laser Therapy, vol. 1, pp. 159-166, 1999. |
Sumian, C.C. et al., “Laser Skin Resurfacing Using a Frequency Doubled Nd:YAG Laser After Topical Application of an Exogenous Chromophore,” Lasers in Surgery and Medicine, vol. 25. pp. 43-50, 1999. |
Sumian et al., “A new method to improve penetration depth of dyes into the follicur duct : . . . ,” J. Am. Acad. Dermotol., 41(2) Part 1:172-175, 1999. |
Tarasov, L. V., Laser Physics, Translated from Russion by Ram S. Wadhwa, MIR publishers, Moscow, pp. 178-181, Chapter 2, 1983. |
Tarijian, et al., “Fractional abalative laser skin resurfacing: A review”, Journal of Cosmetic and Laser Therapy, 13:262-264, ISSN 1476/4172. Informa UK Ltd. Sep. 2011, 3 pages. |
Taylor, C.R. et al., “Treatment of tattoos by Q-switched ruby laser,” Arch. Dermatol. vol. 126, pp. 893-899, Jul. 1990. |
Togatov, V.V. et al., “Electronic discharge module for pump systems of solid-state lasers”, Optical Journal, V. 67, n. 4, pp. 92-96 (2000). |
Tuchin, V.V., “Laser light scattering in biomedical diagnostics and therapy,” Journal of Laser Applications, vol. 5, No. 2-3, pp. 43-60, 1993. |
Unger, W.P., Laser hair transplantation III: Computer-assisted laser transplanting. Dermatol Surg. 1995;21:1047-1055. |
Van Bruegel, “Power Density and Exposure Time of He—Ne Irradiation Are More Important Than Total Energy Dose in Photo-Biomodulation of Human Fibroblasts in Vitro,” Lasers in Surgery and Medicine, vol. 12 pp. 528-537, 1992. |
Vasily, et al., “Non-Ablative Fractional Resurfacing of Surgical and Post-Traumatic Scars”, Journal of Drugs in Dermatology, 8(11):998-1005, Nov. 2009, 8 pages. |
Walsh, “Laser “Curettage”: a Critical Analysis,” Periodontology 14:4-12, 1993. |
Walsh, “The Current Status of Low Level Laser Therapy in Dentistry. Part 1. Soft Tissue Applications,” Aust. Dent. J. Aug. 1997;42(4):247-54. |
Watanabe, S. et al., “Comparative studies of femtosecond to microsecond laser pulses on selective pigmented cell injury in skin,” Photochemistry and Photobiology, vol. 53, No. 6, pp. 757-782, 1991. |
Watanabe, S. et al., “The Effect of Pulse Duration on Selective Pigmented Cell Injury by Dye Lasers,” The Journal of Investigative Dermatology, 88:523, 1987. |
Watson, G. M., MS, “Minimally Invasive Therapies of the Prostate,” Minimally Invasive Therapy, 1:231-240 (1992). |
Wei Tech Ang et al., “Design of All-Accelerometer Inertial Measurement Unit for Tremor Sensing in Hand-Held Microsurgical Instrument,” 2003 IEEE International Conference on Robotics and Automation (vol. 2), Taipei, Taiwan, Sep. 14-19, 2003. |
Wei Tech Ang et al., “Kalman Filtering for Real-Time Orientation Tracking of Handheld Microsurgical Instrument,” 2004 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), Sendai, Japan, Sep. 28-Oct. 2, 2004. |
Welch, A.J. et al., “Evaluation of cooling techniques for the protection of the epidermis during HD-yag laser iradiation of the skin,” Neodymium-Yag Laser in Medicine and Surgery, Elsevier Science Publishing Co., publisher, pp. 195-204, 1983. |
Westerman et al., “Argon Laser Irradiation Effects on Sound Root Surfaces: In Vitro Scanning Electron Microscopic Observations,” Journal of Clinical Laser Medicine and Surgery, vol. 16, No. 2, pp. 111-115, 1998. |
Wilson, S.W., “Passive Alignment of a Semiconductor Laser to an Optical Fiber,” Universirty of Maryland, Master's Thesis (1995). |
Winters, B.H. et al., “Photochemical Products in Coumarin Laser Dyes,” Appl. Phys. Lett. 25:723-724 (1974). |
Yang et al., “Hybrid optoelectronics: A polymer laser pumped by a nitride light emitting diode,” Applied Physics Letters 92, Jan. 23, 2008. |
Yules, R.B. et al., “The effect of Q-switched ruby laser radiation on dermal tattoo pigment in man,” Arch Surg, vol. 95, pp. 179-180, Aug. 1967. |
Zapka et al. “Pulse Slicing and Pockets Cell Shutters,” J. Phys. E: Sci, Instrum., vol. 15 (1982). |
Zayhowski, J.J. et al., “Gain-switched pulsed operation of microchip lasers”, Optice Letters, Optical Society of America, US 14:23, Dec. 1, 1989, pp. 1318-1320. |
Zeitler, E. et al., “Laser Characteristics that Might be Useful in Biology,” Laser Applications in Medicine and Biology, vol. I, M.L. Wolbarsht, editor, Plenum Press, publishers, Chapter 1, pp. 1-18, 1971. |
Zonios et al., “Skin Melanin, Hemoglobin, and Light Scattering Properties can be Quantitatively Assessed in Vivo Using Diffuse Reflectance Spectroscopy,” Journal of Investigative Dermatology,117:1452-1457 (Dec. 2001). |
PCT Written Opinion for PCT International Application No. PCT/US2013/032228, dated Jun. 26, 2013, 7 pages. |
Zayhowski et al., “Miniature Gain-Switched Lasers”, OSA TOPS, vol. 50, Advanced Solid-State Lasers 2001, pp. 462-469. |
Duguay et al., “Picosecond Pulses from an optically pumped ribbon-whisker laser”, Applied Physical Letters, vol. 37, No. 4, Aug. 15, 1980 (pp. 369-370). |
Stone et al., “Optically pumped ultrashort cavity in_1-x Ga_x As_y P_ 1-y lasers: picosecond operation between 0.83 and 1.59 μm”, Optics Letters, vol. 6, No. 11, Nov. 1, 1981, pp. 534-536. |
Supplemental European Search Report for European Application No. 13778882.4, dated Dec. 1, 2015 (7 pages). |
Number | Date | Country | |
---|---|---|---|
20190221989 A1 | Jul 2019 | US |
Number | Date | Country | |
---|---|---|---|
61625961 | Apr 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15721714 | Sep 2017 | US |
Child | 16363597 | US | |
Parent | 14394960 | US | |
Child | 15721714 | US |